GNF SymAtlas + NCI-60 cancer cell lines, comparison of cancers vs non-cancers, human (Su, 2004; Ross, 2000)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
EBF1
|
ENSG00000164330.12 | EBF transcription factor 1 |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr22_+_23229960 | 64.30 |
ENST00000526893.1
ENST00000532223.2 ENST00000531372.1 |
IGLL5
|
immunoglobulin lambda-like polypeptide 5 |
chr16_+_222846 | 61.81 |
ENST00000251595.6
ENST00000397806.1 |
HBA2
|
hemoglobin, alpha 2 |
chr17_+_38083977 | 45.09 |
ENST00000578802.1
ENST00000578478.1 ENST00000582263.1 |
RP11-387H17.4
|
RP11-387H17.4 |
chr11_-_111781454 | 43.57 |
ENST00000533280.1
|
CRYAB
|
crystallin, alpha B |
chr11_-_111794446 | 43.44 |
ENST00000527950.1
|
CRYAB
|
crystallin, alpha B |
chr14_-_21270995 | 42.96 |
ENST00000555698.1
ENST00000397970.4 ENST00000340900.3 |
RNASE1
|
ribonuclease, RNase A family, 1 (pancreatic) |
chr1_-_156217875 | 42.33 |
ENST00000292291.5
|
PAQR6
|
progestin and adipoQ receptor family member VI |
chr5_-_149792295 | 40.13 |
ENST00000518797.1
ENST00000524315.1 ENST00000009530.7 ENST00000377795.3 |
CD74
|
CD74 molecule, major histocompatibility complex, class II invariant chain |
chr1_+_6845384 | 39.80 |
ENST00000303635.7
|
CAMTA1
|
calmodulin binding transcription activator 1 |
chr1_-_156217822 | 39.36 |
ENST00000368270.1
|
PAQR6
|
progestin and adipoQ receptor family member VI |
chr4_-_57522673 | 38.87 |
ENST00000381255.3
ENST00000317745.7 ENST00000555760.2 ENST00000556614.2 |
HOPX
|
HOP homeobox |
chr22_+_23101182 | 38.52 |
ENST00000390312.2
|
IGLV2-14
|
immunoglobulin lambda variable 2-14 |
chr2_+_17935383 | 38.41 |
ENST00000524465.1
ENST00000381254.2 ENST00000532257.1 |
GEN1
|
GEN1 Holliday junction 5' flap endonuclease |
chr1_-_156217829 | 38.38 |
ENST00000356983.2
ENST00000335852.1 ENST00000340183.5 ENST00000540423.1 |
PAQR6
|
progestin and adipoQ receptor family member VI |
chr11_-_111781610 | 37.98 |
ENST00000525823.1
|
CRYAB
|
crystallin, alpha B |
chr4_-_5891918 | 36.64 |
ENST00000512574.1
|
CRMP1
|
collapsin response mediator protein 1 |
chr4_-_57522598 | 36.03 |
ENST00000553379.2
|
HOPX
|
HOP homeobox |
chr11_-_111781554 | 35.34 |
ENST00000526167.1
ENST00000528961.1 |
CRYAB
|
crystallin, alpha B |
chr14_+_22984601 | 33.45 |
ENST00000390509.1
|
TRAJ28
|
T cell receptor alpha joining 28 |
chr2_+_17935119 | 32.96 |
ENST00000317402.7
|
GEN1
|
GEN1 Holliday junction 5' flap endonuclease |
chr12_+_10365404 | 32.46 |
ENST00000266458.5
ENST00000421801.2 ENST00000544284.1 ENST00000545047.1 ENST00000543602.1 ENST00000545887.1 |
GABARAPL1
|
GABA(A) receptor-associated protein like 1 |
chr19_-_38720294 | 31.37 |
ENST00000412732.1
ENST00000456296.1 |
DPF1
|
D4, zinc and double PHD fingers family 1 |
chr19_-_37019562 | 30.95 |
ENST00000523638.1
|
ZNF260
|
zinc finger protein 260 |
chr2_-_176866978 | 30.92 |
ENST00000392540.2
ENST00000409660.1 ENST00000544803.1 ENST00000272748.4 |
KIAA1715
|
KIAA1715 |
chr13_-_30881621 | 30.86 |
ENST00000380615.3
|
KATNAL1
|
katanin p60 subunit A-like 1 |
chr11_-_117748138 | 30.38 |
ENST00000527717.1
|
FXYD6
|
FXYD domain containing ion transport regulator 6 |
chr19_-_37019136 | 30.00 |
ENST00000592282.1
|
ZNF260
|
zinc finger protein 260 |
chr5_-_42825983 | 29.96 |
ENST00000506577.1
|
SEPP1
|
selenoprotein P, plasma, 1 |
chr19_+_35630628 | 29.30 |
ENST00000588715.1
ENST00000588607.1 |
FXYD1
|
FXYD domain containing ion transport regulator 1 |
chr1_+_152635854 | 28.31 |
ENST00000368784.1
|
LCE2D
|
late cornified envelope 2D |
chr19_+_49622646 | 27.68 |
ENST00000334186.4
|
PPFIA3
|
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 3 |
chr14_-_21270561 | 27.44 |
ENST00000412779.2
|
RNASE1
|
ribonuclease, RNase A family, 1 (pancreatic) |
chr1_-_156390128 | 26.21 |
ENST00000368242.3
|
C1orf61
|
chromosome 1 open reading frame 61 |
chr7_+_24323782 | 26.19 |
ENST00000242152.2
ENST00000407573.1 |
NPY
|
neuropeptide Y |
chr8_-_70983506 | 26.08 |
ENST00000276594.2
|
PRDM14
|
PR domain containing 14 |
chr8_-_22089533 | 26.03 |
ENST00000321613.3
|
PHYHIP
|
phytanoyl-CoA 2-hydroxylase interacting protein |
chr3_-_58563094 | 25.99 |
ENST00000464064.1
|
FAM107A
|
family with sequence similarity 107, member A |
chr8_+_136470270 | 25.95 |
ENST00000524199.1
|
KHDRBS3
|
KH domain containing, RNA binding, signal transduction associated 3 |
chr22_+_23165153 | 25.53 |
ENST00000390317.2
|
IGLV2-8
|
immunoglobulin lambda variable 2-8 |
chr12_+_53443963 | 25.44 |
ENST00000546602.1
ENST00000552570.1 ENST00000549700.1 |
TENC1
|
tensin like C1 domain containing phosphatase (tensin 2) |
chr19_-_38720354 | 25.29 |
ENST00000416611.1
|
DPF1
|
D4, zinc and double PHD fingers family 1 |
chr6_+_33043703 | 25.19 |
ENST00000418931.2
ENST00000535465.1 |
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1 |
chr12_+_53443680 | 24.69 |
ENST00000314250.6
ENST00000451358.1 |
TENC1
|
tensin like C1 domain containing phosphatase (tensin 2) |
chr1_+_2005425 | 23.69 |
ENST00000461106.2
|
PRKCZ
|
protein kinase C, zeta |
chr19_+_35630926 | 23.68 |
ENST00000588081.1
ENST00000589121.1 |
FXYD1
|
FXYD domain containing ion transport regulator 1 |
chr6_-_31514333 | 23.48 |
ENST00000376151.4
|
ATP6V1G2
|
ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2 |
chr6_-_46459099 | 23.37 |
ENST00000371374.1
|
RCAN2
|
regulator of calcineurin 2 |
chr4_+_4388805 | 23.34 |
ENST00000504171.1
|
NSG1
|
Homo sapiens neuron specific gene family member 1 (NSG1), transcript variant 3, mRNA. |
chr22_-_19512893 | 23.16 |
ENST00000403084.1
ENST00000413119.2 |
CLDN5
|
claudin 5 |
chr1_-_20812690 | 23.15 |
ENST00000375078.3
|
CAMK2N1
|
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
chr1_+_44115814 | 22.56 |
ENST00000372396.3
|
KDM4A
|
lysine (K)-specific demethylase 4A |
chr10_+_106034884 | 22.41 |
ENST00000369707.2
ENST00000429569.2 |
GSTO2
|
glutathione S-transferase omega 2 |
chr8_+_21911054 | 22.36 |
ENST00000519850.1
ENST00000381470.3 |
DMTN
|
dematin actin binding protein |
chr16_-_21289627 | 22.34 |
ENST00000396023.2
ENST00000415987.2 |
CRYM
|
crystallin, mu |
chr19_+_50706866 | 21.67 |
ENST00000440075.2
ENST00000376970.2 ENST00000425460.1 ENST00000599920.1 ENST00000601313.1 |
MYH14
|
myosin, heavy chain 14, non-muscle |
chr19_+_17326141 | 21.56 |
ENST00000445667.2
ENST00000263897.5 |
USE1
|
unconventional SNARE in the ER 1 homolog (S. cerevisiae) |
chr19_+_17326521 | 21.35 |
ENST00000593597.1
|
USE1
|
unconventional SNARE in the ER 1 homolog (S. cerevisiae) |
chr10_+_101089107 | 21.35 |
ENST00000446890.1
ENST00000370528.3 |
CNNM1
|
cyclin M1 |
chr11_+_121447469 | 21.33 |
ENST00000532694.1
ENST00000534286.1 |
SORL1
|
sortilin-related receptor, L(DLR class) A repeats containing |
chr12_-_123215306 | 21.21 |
ENST00000356987.2
ENST00000436083.2 |
HCAR1
|
hydroxycarboxylic acid receptor 1 |
chr19_+_50380917 | 21.17 |
ENST00000535102.2
|
TBC1D17
|
TBC1 domain family, member 17 |
chr14_+_95078714 | 21.11 |
ENST00000393078.3
ENST00000393080.4 ENST00000467132.1 |
SERPINA3
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3 |
chr4_-_681114 | 21.07 |
ENST00000503156.1
|
MFSD7
|
major facilitator superfamily domain containing 7 |
chr19_-_49945617 | 20.99 |
ENST00000600601.1
ENST00000543531.1 |
SLC17A7
|
solute carrier family 17 (vesicular glutamate transporter), member 7 |
chr1_+_35225339 | 20.97 |
ENST00000339480.1
|
GJB4
|
gap junction protein, beta 4, 30.3kDa |
chr12_-_71182695 | 20.94 |
ENST00000342084.4
|
PTPRR
|
protein tyrosine phosphatase, receptor type, R |
chr14_+_73704201 | 20.93 |
ENST00000340738.5
ENST00000427855.1 ENST00000381166.3 |
PAPLN
|
papilin, proteoglycan-like sulfated glycoprotein |
chr19_+_17326191 | 20.87 |
ENST00000595101.1
ENST00000596136.1 ENST00000379776.4 |
USE1
|
unconventional SNARE in the ER 1 homolog (S. cerevisiae) |
chr14_-_106174960 | 20.83 |
ENST00000390547.2
|
IGHA1
|
immunoglobulin heavy constant alpha 1 |
chr14_-_21493884 | 20.54 |
ENST00000556974.1
ENST00000554419.1 ENST00000298687.5 ENST00000397858.1 ENST00000360463.3 ENST00000350792.3 ENST00000397847.2 |
NDRG2
|
NDRG family member 2 |
chr8_-_144241664 | 20.46 |
ENST00000342752.4
|
LY6H
|
lymphocyte antigen 6 complex, locus H |
chr4_+_156588350 | 20.44 |
ENST00000296518.7
|
GUCY1A3
|
guanylate cyclase 1, soluble, alpha 3 |
chr1_-_11866034 | 20.20 |
ENST00000376590.3
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H) |
chr15_+_44580899 | 20.13 |
ENST00000559222.1
ENST00000299957.6 |
CASC4
|
cancer susceptibility candidate 4 |
chr16_-_70472946 | 20.02 |
ENST00000342907.2
|
ST3GAL2
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 2 |
chr19_-_49137790 | 19.93 |
ENST00000599385.1
|
DBP
|
D site of albumin promoter (albumin D-box) binding protein |
chr8_-_144242020 | 19.92 |
ENST00000414417.2
|
LY6H
|
lymphocyte antigen 6 complex, locus H |
chr4_+_2965307 | 19.69 |
ENST00000398051.4
ENST00000503518.2 ENST00000398052.4 ENST00000345167.6 ENST00000504933.1 ENST00000442472.2 |
GRK4
|
G protein-coupled receptor kinase 4 |
chr20_+_44657845 | 19.57 |
ENST00000243964.3
|
SLC12A5
|
solute carrier family 12 (potassium/chloride transporter), member 5 |
chr5_+_156712372 | 19.51 |
ENST00000541131.1
|
CYFIP2
|
cytoplasmic FMR1 interacting protein 2 |
chr22_+_23134974 | 19.50 |
ENST00000390314.2
|
IGLV2-11
|
immunoglobulin lambda variable 2-11 |
chr8_-_98290087 | 19.49 |
ENST00000322128.3
|
TSPYL5
|
TSPY-like 5 |
chr14_-_106054659 | 19.45 |
ENST00000390539.2
|
IGHA2
|
immunoglobulin heavy constant alpha 2 (A2m marker) |
chr4_+_128554081 | 19.36 |
ENST00000335251.6
ENST00000296461.5 |
INTU
|
inturned planar cell polarity protein |
chr17_-_43045439 | 19.36 |
ENST00000253407.3
|
C1QL1
|
complement component 1, q subcomponent-like 1 |
chr16_+_10479906 | 19.32 |
ENST00000562527.1
ENST00000396560.2 ENST00000396559.1 ENST00000562102.1 ENST00000543967.1 ENST00000569939.1 ENST00000569900.1 |
ATF7IP2
|
activating transcription factor 7 interacting protein 2 |
chr8_+_28747884 | 19.30 |
ENST00000287701.10
ENST00000444075.1 ENST00000403668.2 ENST00000519662.1 ENST00000558662.1 ENST00000523613.1 ENST00000560599.1 ENST00000397358.3 |
HMBOX1
|
homeobox containing 1 |
chr4_-_57522470 | 19.17 |
ENST00000503639.3
|
HOPX
|
HOP homeobox |
chr4_-_186877502 | 19.12 |
ENST00000431902.1
ENST00000284776.7 ENST00000415274.1 |
SORBS2
|
sorbin and SH3 domain containing 2 |
chr16_+_28834303 | 18.89 |
ENST00000340394.8
ENST00000325215.6 ENST00000395547.2 ENST00000336783.4 ENST00000382686.4 ENST00000564304.1 |
ATXN2L
|
ataxin 2-like |
chr22_-_45559642 | 18.79 |
ENST00000426282.2
|
CTA-217C2.1
|
CTA-217C2.1 |
chr14_-_21493649 | 18.73 |
ENST00000553442.1
ENST00000555869.1 ENST00000556457.1 ENST00000397844.2 ENST00000554415.1 |
NDRG2
|
NDRG family member 2 |
chr1_+_22964073 | 18.60 |
ENST00000402322.1
|
C1QA
|
complement component 1, q subcomponent, A chain |
chr1_-_161519579 | 18.54 |
ENST00000426740.1
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a) |
chr1_-_161279749 | 18.47 |
ENST00000533357.1
ENST00000360451.6 ENST00000336559.4 |
MPZ
|
myelin protein zero |
chr9_-_86571628 | 18.46 |
ENST00000376344.3
|
C9orf64
|
chromosome 9 open reading frame 64 |
chr3_+_49027308 | 18.46 |
ENST00000383729.4
ENST00000343546.4 |
P4HTM
|
prolyl 4-hydroxylase, transmembrane (endoplasmic reticulum) |
chr15_+_44580955 | 18.42 |
ENST00000345795.2
ENST00000360824.3 |
CASC4
|
cancer susceptibility candidate 4 |
chr11_+_117063295 | 18.37 |
ENST00000525478.1
ENST00000532062.1 |
SIDT2
|
SID1 transmembrane family, member 2 |
chr7_+_65338230 | 18.09 |
ENST00000360768.3
|
VKORC1L1
|
vitamin K epoxide reductase complex, subunit 1-like 1 |
chr12_+_21679220 | 18.07 |
ENST00000256969.2
|
C12orf39
|
chromosome 12 open reading frame 39 |
chr8_-_80680078 | 18.04 |
ENST00000337919.5
ENST00000354724.3 |
HEY1
|
hes-related family bHLH transcription factor with YRPW motif 1 |
chr9_-_98079965 | 17.98 |
ENST00000289081.3
|
FANCC
|
Fanconi anemia, complementation group C |
chr20_-_4804244 | 17.98 |
ENST00000379400.3
|
RASSF2
|
Ras association (RalGDS/AF-6) domain family member 2 |
chr14_+_24630465 | 17.93 |
ENST00000557894.1
ENST00000559284.1 ENST00000560275.1 |
IRF9
|
interferon regulatory factor 9 |
chr19_-_49137762 | 17.92 |
ENST00000593500.1
|
DBP
|
D site of albumin promoter (albumin D-box) binding protein |
chr5_-_138725560 | 17.76 |
ENST00000412103.2
ENST00000457570.2 |
MZB1
|
marginal zone B and B1 cell-specific protein |
chr1_-_161519682 | 17.68 |
ENST00000367969.3
ENST00000443193.1 |
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a) |
chr3_-_49907323 | 17.67 |
ENST00000296471.7
ENST00000488336.1 ENST00000467248.1 ENST00000466940.1 ENST00000463537.1 ENST00000480398.2 |
CAMKV
|
CaM kinase-like vesicle-associated |
chr3_-_38071122 | 17.66 |
ENST00000334661.4
|
PLCD1
|
phospholipase C, delta 1 |
chr22_+_23040274 | 17.65 |
ENST00000390306.2
|
IGLV2-23
|
immunoglobulin lambda variable 2-23 |
chr20_+_42143136 | 17.57 |
ENST00000373134.1
|
L3MBTL1
|
l(3)mbt-like 1 (Drosophila) |
chr1_+_1981890 | 17.57 |
ENST00000378567.3
ENST00000468310.1 |
PRKCZ
|
protein kinase C, zeta |
chr1_+_160097462 | 17.50 |
ENST00000447527.1
|
ATP1A2
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide |
chr7_+_102715315 | 17.47 |
ENST00000428183.2
ENST00000323716.3 ENST00000441711.2 ENST00000454559.1 ENST00000425331.1 ENST00000541300.1 |
ARMC10
|
armadillo repeat containing 10 |
chr15_+_41136586 | 17.23 |
ENST00000431806.1
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
chr5_-_138725594 | 17.16 |
ENST00000302125.8
|
MZB1
|
marginal zone B and B1 cell-specific protein |
chr12_-_89919965 | 17.12 |
ENST00000548729.1
|
POC1B-GALNT4
|
POC1B-GALNT4 readthrough |
chr1_-_213031418 | 17.00 |
ENST00000356684.3
ENST00000426161.1 ENST00000424044.1 |
FLVCR1-AS1
|
FLVCR1 antisense RNA 1 (head to head) |
chr1_+_150229554 | 16.93 |
ENST00000369111.4
|
CA14
|
carbonic anhydrase XIV |
chr17_+_43972010 | 16.80 |
ENST00000334239.8
ENST00000446361.3 |
MAPT
|
microtubule-associated protein tau |
chr16_+_30662360 | 16.72 |
ENST00000542965.2
|
PRR14
|
proline rich 14 |
chr1_-_203320617 | 16.66 |
ENST00000354955.4
|
FMOD
|
fibromodulin |
chr16_-_30102547 | 16.65 |
ENST00000279386.2
|
TBX6
|
T-box 6 |
chr19_-_3028354 | 16.56 |
ENST00000586422.1
|
TLE2
|
transducin-like enhancer of split 2 (E(sp1) homolog, Drosophila) |
chr5_+_148786423 | 16.54 |
ENST00000505254.2
ENST00000602964.1 ENST00000519898.1 |
MIR143HG
|
MIR143 host gene (non-protein coding) |
chr20_+_42143053 | 16.52 |
ENST00000373135.3
ENST00000444063.1 |
L3MBTL1
|
l(3)mbt-like 1 (Drosophila) |
chr16_+_1583567 | 16.52 |
ENST00000566264.1
|
TMEM204
|
transmembrane protein 204 |
chr22_+_29138013 | 16.47 |
ENST00000216027.3
ENST00000398941.2 |
HSCB
|
HscB mitochondrial iron-sulfur cluster co-chaperone |
chr2_+_89986318 | 16.47 |
ENST00000491977.1
|
IGKV2D-29
|
immunoglobulin kappa variable 2D-29 |
chr1_+_151254738 | 16.47 |
ENST00000336715.6
ENST00000324048.5 ENST00000368879.2 |
ZNF687
|
zinc finger protein 687 |
chr2_-_71454185 | 16.21 |
ENST00000244221.8
|
PAIP2B
|
poly(A) binding protein interacting protein 2B |
chr12_-_50290839 | 16.17 |
ENST00000552863.1
|
FAIM2
|
Fas apoptotic inhibitory molecule 2 |
chr6_-_90025011 | 16.17 |
ENST00000402938.3
|
GABRR2
|
gamma-aminobutyric acid (GABA) A receptor, rho 2 |
chr7_-_137028534 | 16.16 |
ENST00000348225.2
|
PTN
|
pleiotrophin |
chr4_-_17812309 | 16.13 |
ENST00000382247.1
ENST00000536863.1 |
DCAF16
|
DDB1 and CUL4 associated factor 16 |
chr19_+_16435625 | 16.13 |
ENST00000248071.5
ENST00000592003.1 |
KLF2
|
Kruppel-like factor 2 |
chr14_-_21493123 | 16.13 |
ENST00000556147.1
ENST00000554489.1 ENST00000555657.1 ENST00000557274.1 ENST00000555158.1 ENST00000554833.1 ENST00000555384.1 ENST00000556420.1 ENST00000554893.1 ENST00000553503.1 ENST00000555733.1 ENST00000553867.1 ENST00000397856.3 ENST00000397855.3 ENST00000556008.1 ENST00000557182.1 ENST00000554483.1 ENST00000556688.1 ENST00000397853.3 ENST00000556329.2 ENST00000554143.1 ENST00000397851.2 ENST00000555142.1 ENST00000557676.1 ENST00000556924.1 |
NDRG2
|
NDRG family member 2 |
chr8_+_144816303 | 16.10 |
ENST00000533004.1
|
FAM83H-AS1
|
FAM83H antisense RNA 1 (head to head) |
chr17_-_18585541 | 16.06 |
ENST00000285274.5
ENST00000545289.1 ENST00000580145.1 |
ZNF286B
|
zinc finger protein 286B |
chr3_+_38347427 | 16.03 |
ENST00000273173.4
|
SLC22A14
|
solute carrier family 22, member 14 |
chr3_+_111717511 | 16.03 |
ENST00000478951.1
ENST00000393917.2 |
TAGLN3
|
transgelin 3 |
chr19_-_54872556 | 16.00 |
ENST00000444687.1
|
LAIR1
|
leukocyte-associated immunoglobulin-like receptor 1 |
chr6_-_28367510 | 15.99 |
ENST00000361028.1
|
ZSCAN12
|
zinc finger and SCAN domain containing 12 |
chr17_+_8339164 | 15.93 |
ENST00000582665.1
ENST00000334527.7 ENST00000299734.7 |
NDEL1
|
nudE neurodevelopment protein 1-like 1 |
chr11_-_132813566 | 15.93 |
ENST00000331898.7
|
OPCML
|
opioid binding protein/cell adhesion molecule-like |
chr10_+_101088836 | 15.88 |
ENST00000356713.4
|
CNNM1
|
cyclin M1 |
chr1_-_21995794 | 15.85 |
ENST00000542643.2
ENST00000374765.4 ENST00000317967.7 |
RAP1GAP
|
RAP1 GTPase activating protein |
chr19_+_2867325 | 15.80 |
ENST00000307635.2
ENST00000586426.1 |
ZNF556
|
zinc finger protein 556 |
chr15_-_83378611 | 15.74 |
ENST00000542200.1
|
AP3B2
|
adaptor-related protein complex 3, beta 2 subunit |
chr8_-_19459993 | 15.71 |
ENST00000454498.2
ENST00000520003.1 |
CSGALNACT1
|
chondroitin sulfate N-acetylgalactosaminyltransferase 1 |
chr19_+_50381308 | 15.70 |
ENST00000599049.2
|
TBC1D17
|
TBC1 domain family, member 17 |
chr5_+_74807886 | 15.62 |
ENST00000514296.1
|
POLK
|
polymerase (DNA directed) kappa |
chr19_-_4454081 | 15.61 |
ENST00000591919.1
|
UBXN6
|
UBX domain protein 6 |
chr1_+_45805728 | 15.60 |
ENST00000539779.1
|
TOE1
|
target of EGR1, member 1 (nuclear) |
chr20_+_61436146 | 15.60 |
ENST00000290291.6
|
OGFR
|
opioid growth factor receptor |
chr14_-_101036119 | 15.49 |
ENST00000355173.2
|
BEGAIN
|
brain-enriched guanylate kinase-associated |
chr17_+_43971643 | 15.38 |
ENST00000344290.5
ENST00000262410.5 ENST00000351559.5 ENST00000340799.5 ENST00000535772.1 ENST00000347967.5 |
MAPT
|
microtubule-associated protein tau |
chr14_-_101034407 | 15.26 |
ENST00000443071.2
ENST00000557378.1 |
BEGAIN
|
brain-enriched guanylate kinase-associated |
chr8_-_27469196 | 15.23 |
ENST00000546343.1
ENST00000560566.1 |
CLU
|
clusterin |
chr17_-_79105734 | 15.18 |
ENST00000417379.1
|
AATK
|
apoptosis-associated tyrosine kinase |
chr7_+_24324726 | 15.16 |
ENST00000405982.1
|
NPY
|
neuropeptide Y |
chr17_-_62009702 | 15.15 |
ENST00000006750.3
|
CD79B
|
CD79b molecule, immunoglobulin-associated beta |
chr12_+_57522258 | 15.04 |
ENST00000553277.1
ENST00000243077.3 |
LRP1
|
low density lipoprotein receptor-related protein 1 |
chr17_-_46507567 | 15.03 |
ENST00000584924.1
|
SKAP1
|
src kinase associated phosphoprotein 1 |
chr11_+_43380459 | 14.98 |
ENST00000299240.6
ENST00000039989.4 |
TTC17
|
tetratricopeptide repeat domain 17 |
chr12_+_1100370 | 14.98 |
ENST00000543086.3
ENST00000546231.2 ENST00000397203.2 |
ERC1
|
ELKS/RAB6-interacting/CAST family member 1 |
chr19_-_45826125 | 14.95 |
ENST00000221476.3
|
CKM
|
creatine kinase, muscle |
chr20_+_1246908 | 14.94 |
ENST00000381873.3
ENST00000381867.1 |
SNPH
|
syntaphilin |
chr11_+_65479702 | 14.88 |
ENST00000530446.1
ENST00000534104.1 ENST00000530605.1 ENST00000528198.1 ENST00000531880.1 ENST00000534650.1 |
KAT5
|
K(lysine) acetyltransferase 5 |
chr8_-_144241432 | 14.86 |
ENST00000430474.2
|
LY6H
|
lymphocyte antigen 6 complex, locus H |
chr10_+_104474207 | 14.82 |
ENST00000602831.1
ENST00000369893.5 |
SFXN2
|
sideroflexin 2 |
chr19_-_57183114 | 14.79 |
ENST00000537055.2
ENST00000601659.1 |
ZNF835
|
zinc finger protein 835 |
chrX_+_128913906 | 14.77 |
ENST00000356892.3
|
SASH3
|
SAM and SH3 domain containing 3 |
chr1_-_113162040 | 14.71 |
ENST00000358039.4
ENST00000369668.2 |
ST7L
|
suppression of tumorigenicity 7 like |
chr9_+_130965651 | 14.69 |
ENST00000475805.1
ENST00000341179.7 ENST00000372923.3 |
DNM1
|
dynamin 1 |
chr4_+_8594435 | 14.64 |
ENST00000382480.2
|
CPZ
|
carboxypeptidase Z |
chr19_-_7939319 | 14.62 |
ENST00000539422.1
|
CTD-3193O13.9
|
Protein FLJ22184 |
chr10_+_76586348 | 14.58 |
ENST00000372724.1
ENST00000287239.4 ENST00000372714.1 |
KAT6B
|
K(lysine) acetyltransferase 6B |
chr1_+_27114589 | 14.58 |
ENST00000431541.1
ENST00000449950.2 ENST00000374145.1 |
PIGV
|
phosphatidylinositol glycan anchor biosynthesis, class V |
chr10_-_90751038 | 14.56 |
ENST00000458159.1
ENST00000415557.1 ENST00000458208.1 |
ACTA2
|
actin, alpha 2, smooth muscle, aorta |
chr11_+_17741111 | 14.55 |
ENST00000250003.3
|
MYOD1
|
myogenic differentiation 1 |
chr1_+_33352036 | 14.54 |
ENST00000373467.3
|
HPCA
|
hippocalcin |
chr11_+_73019282 | 14.53 |
ENST00000263674.3
|
ARHGEF17
|
Rho guanine nucleotide exchange factor (GEF) 17 |
chr10_-_71176623 | 14.46 |
ENST00000373306.4
|
TACR2
|
tachykinin receptor 2 |
chr17_-_62009621 | 14.42 |
ENST00000349817.2
ENST00000392795.3 |
CD79B
|
CD79b molecule, immunoglobulin-associated beta |
chr22_-_37213554 | 14.35 |
ENST00000443735.1
|
PVALB
|
parvalbumin |
chr19_+_2977444 | 14.34 |
ENST00000246112.4
ENST00000453329.1 ENST00000482627.1 ENST00000452088.1 |
TLE6
|
transducin-like enhancer of split 6 (E(sp1) homolog, Drosophila) |
chr6_-_46293378 | 14.34 |
ENST00000330430.6
|
RCAN2
|
regulator of calcineurin 2 |
chr12_-_51717948 | 14.33 |
ENST00000267012.4
|
BIN2
|
bridging integrator 2 |
chr9_+_130965677 | 14.26 |
ENST00000393594.3
ENST00000486160.1 |
DNM1
|
dynamin 1 |
chr17_-_56606705 | 14.24 |
ENST00000317268.3
|
SEPT4
|
septin 4 |
chr14_-_22005062 | 14.20 |
ENST00000317492.5
|
SALL2
|
spalt-like transcription factor 2 |
chr1_+_213123976 | 14.07 |
ENST00000366965.2
ENST00000366967.2 |
VASH2
|
vasohibin 2 |
chr6_-_46459675 | 14.03 |
ENST00000306764.7
|
RCAN2
|
regulator of calcineurin 2 |
chr17_-_40333099 | 14.03 |
ENST00000607371.1
|
KCNH4
|
potassium voltage-gated channel, subfamily H (eag-related), member 4 |
chr2_-_24583314 | 14.01 |
ENST00000443927.1
ENST00000406921.3 ENST00000412011.1 |
ITSN2
|
intersectin 2 |
chr2_+_233497931 | 14.00 |
ENST00000264059.3
|
EFHD1
|
EF-hand domain family, member D1 |
chr6_-_90024967 | 13.99 |
ENST00000602399.1
|
GABRR2
|
gamma-aminobutyric acid (GABA) A receptor, rho 2 |
chr1_-_45805752 | 13.97 |
ENST00000354383.6
ENST00000355498.2 ENST00000372100.5 ENST00000531105.1 |
MUTYH
|
mutY homolog |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
23.8 | 71.4 | GO:0071139 | resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
12.9 | 38.7 | GO:1904395 | positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
12.2 | 36.6 | GO:1904617 | negative regulation of actin filament binding(GO:1904530) negative regulation of actin binding(GO:1904617) |
11.8 | 70.6 | GO:0010732 | protein glutathionylation(GO:0010731) regulation of protein glutathionylation(GO:0010732) negative regulation of protein glutathionylation(GO:0010734) |
10.3 | 51.3 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
9.8 | 78.7 | GO:0002606 | positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
9.6 | 28.9 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
8.7 | 156.5 | GO:0007021 | tubulin complex assembly(GO:0007021) |
8.7 | 26.1 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
8.7 | 26.0 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
8.5 | 25.6 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
8.5 | 42.6 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
8.4 | 25.2 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
8.4 | 25.1 | GO:0002881 | negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
7.9 | 15.9 | GO:0045214 | sarcomere organization(GO:0045214) |
7.8 | 54.4 | GO:0045007 | depurination(GO:0045007) |
7.6 | 37.9 | GO:0051946 | regulation of amino acid uptake involved in synaptic transmission(GO:0051941) regulation of glutamate uptake involved in transmission of nerve impulse(GO:0051946) regulation of L-glutamate import(GO:1900920) |
7.2 | 14.5 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
7.2 | 28.9 | GO:1900827 | positive regulation of cell communication by electrical coupling(GO:0010650) maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
7.1 | 21.3 | GO:1902769 | regulation of choline O-acetyltransferase activity(GO:1902769) positive regulation of choline O-acetyltransferase activity(GO:1902771) negative regulation of tau-protein kinase activity(GO:1902948) positive regulation of early endosome to recycling endosome transport(GO:1902955) negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902960) negative regulation of neurofibrillary tangle assembly(GO:1902997) negative regulation of aspartic-type peptidase activity(GO:1905246) |
7.0 | 34.9 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
6.9 | 41.3 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
6.8 | 34.0 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
6.6 | 6.6 | GO:0071878 | negative regulation of adrenergic receptor signaling pathway(GO:0071878) |
6.5 | 19.4 | GO:0048213 | Golgi vesicle prefusion complex stabilization(GO:0048213) |
6.4 | 19.3 | GO:0048611 | ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
6.4 | 19.2 | GO:1990502 | dense core granule maturation(GO:1990502) |
6.4 | 6.4 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
6.2 | 24.8 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
5.9 | 41.3 | GO:0032100 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
5.8 | 17.4 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
5.4 | 21.7 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
5.4 | 16.1 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
5.3 | 16.0 | GO:0061537 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
5.3 | 31.8 | GO:0090238 | positive regulation of arachidonic acid secretion(GO:0090238) |
5.3 | 15.9 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
5.1 | 30.9 | GO:0051013 | microtubule severing(GO:0051013) |
5.1 | 15.3 | GO:0009447 | putrescine catabolic process(GO:0009447) |
5.0 | 15.0 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) regulation of skeletal muscle fiber differentiation(GO:1902809) |
5.0 | 25.0 | GO:0051622 | negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) regulation of peroxidase activity(GO:2000468) positive regulation of peroxidase activity(GO:2000470) |
4.9 | 19.6 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
4.8 | 19.4 | GO:0061743 | motor learning(GO:0061743) |
4.8 | 14.3 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
4.6 | 18.5 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
4.6 | 32.3 | GO:0071907 | determination of digestive tract left/right asymmetry(GO:0071907) |
4.6 | 105.5 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
4.6 | 13.7 | GO:0035378 | carbon dioxide transmembrane transport(GO:0035378) |
4.5 | 18.0 | GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
4.4 | 26.6 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
4.4 | 13.2 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
4.4 | 43.7 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
4.3 | 12.9 | GO:1902595 | regulation of DNA replication origin binding(GO:1902595) |
4.3 | 25.5 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
4.2 | 12.6 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
4.2 | 20.8 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
4.1 | 4.1 | GO:1904379 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
4.1 | 16.4 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
4.1 | 12.3 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
4.1 | 12.2 | GO:1904604 | regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904596) negative regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904597) regulation of advanced glycation end-product receptor activity(GO:1904603) negative regulation of advanced glycation end-product receptor activity(GO:1904604) negative regulation of connective tissue replacement(GO:1905204) |
4.0 | 44.5 | GO:0033227 | dsRNA transport(GO:0033227) |
4.0 | 20.2 | GO:0033274 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
4.0 | 16.0 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
4.0 | 12.0 | GO:0009183 | ADP biosynthetic process(GO:0006172) purine deoxyribonucleoside diphosphate biosynthetic process(GO:0009183) |
3.9 | 31.5 | GO:0051480 | regulation of cytosolic calcium ion concentration(GO:0051480) |
3.9 | 15.7 | GO:0097477 | spinal cord motor neuron migration(GO:0097476) lateral motor column neuron migration(GO:0097477) |
3.9 | 7.9 | GO:1902081 | regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
3.9 | 15.7 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
3.9 | 15.5 | GO:2001295 | malonyl-CoA biosynthetic process(GO:2001295) |
3.9 | 11.6 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
3.8 | 11.5 | GO:0002894 | positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
3.8 | 26.8 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
3.8 | 11.5 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
3.8 | 30.4 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
3.8 | 26.5 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
3.8 | 15.1 | GO:0010903 | negative regulation of very-low-density lipoprotein particle remodeling(GO:0010903) |
3.7 | 22.4 | GO:0070560 | protein secretion by platelet(GO:0070560) |
3.7 | 14.9 | GO:0097676 | histone H3-K36 dimethylation(GO:0097676) |
3.7 | 3.7 | GO:0071623 | negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of neutrophil chemotaxis(GO:0090024) negative regulation of neutrophil migration(GO:1902623) |
3.7 | 11.2 | GO:0086092 | regulation of the force of heart contraction by cardiac conduction(GO:0086092) |
3.7 | 11.1 | GO:0035621 | ER to Golgi ceramide transport(GO:0035621) |
3.7 | 18.5 | GO:0035106 | operant conditioning(GO:0035106) |
3.6 | 14.5 | GO:1902075 | cellular response to salt(GO:1902075) |
3.6 | 32.6 | GO:0008090 | retrograde axonal transport(GO:0008090) |
3.6 | 10.8 | GO:0046949 | fatty-acyl-CoA biosynthetic process(GO:0046949) |
3.6 | 3.6 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
3.6 | 14.3 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
3.5 | 10.6 | GO:2000824 | negative regulation of androgen receptor activity(GO:2000824) |
3.5 | 14.1 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
3.5 | 10.5 | GO:0030239 | myofibril assembly(GO:0030239) |
3.4 | 6.9 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
3.4 | 20.4 | GO:0052551 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
3.4 | 10.1 | GO:0097018 | renal albumin absorption(GO:0097018) regulation of renal albumin absorption(GO:2000532) regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000583) negative regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000584) |
3.4 | 23.5 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
3.4 | 53.7 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
3.3 | 6.6 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
3.3 | 10.0 | GO:1900075 | regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
3.2 | 39.0 | GO:0021702 | cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
3.2 | 3.2 | GO:0038129 | ERBB3 signaling pathway(GO:0038129) |
3.2 | 19.4 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
3.2 | 28.9 | GO:0006477 | protein sulfation(GO:0006477) |
3.2 | 15.9 | GO:0033590 | response to cobalamin(GO:0033590) |
3.2 | 9.5 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
3.2 | 9.5 | GO:0090675 | intermicrovillar adhesion(GO:0090675) |
3.2 | 9.5 | GO:0021718 | superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
3.1 | 9.3 | GO:0038178 | complement component C5a signaling pathway(GO:0038178) |
3.1 | 12.4 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
3.1 | 12.3 | GO:0042321 | negative regulation of circadian sleep/wake cycle, sleep(GO:0042321) |
3.1 | 15.3 | GO:1903971 | positive regulation of odontogenesis of dentin-containing tooth(GO:0042488) mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) positive regulation of microglial cell migration(GO:1904141) |
3.0 | 8.9 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
3.0 | 8.9 | GO:0006566 | threonine metabolic process(GO:0006566) |
3.0 | 11.8 | GO:0021633 | optic nerve structural organization(GO:0021633) |
2.9 | 8.8 | GO:0030186 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
2.9 | 17.6 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
2.9 | 8.7 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
2.9 | 23.3 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
2.9 | 14.6 | GO:0090131 | mesenchyme migration(GO:0090131) |
2.9 | 5.8 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
2.9 | 8.6 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
2.9 | 8.6 | GO:0060086 | circadian temperature homeostasis(GO:0060086) |
2.8 | 5.7 | GO:0030801 | positive regulation of cyclic nucleotide metabolic process(GO:0030801) |
2.8 | 11.4 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
2.8 | 25.5 | GO:0042048 | olfactory behavior(GO:0042048) |
2.8 | 22.6 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) negative regulation of histone H3-K9 trimethylation(GO:1900113) |
2.8 | 8.4 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
2.8 | 8.3 | GO:0044805 | late nucleophagy(GO:0044805) |
2.8 | 16.6 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
2.8 | 2.8 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
2.8 | 13.8 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
2.8 | 8.3 | GO:1904637 | response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
2.8 | 16.6 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
2.7 | 10.9 | GO:0072366 | regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
2.7 | 8.1 | GO:0061107 | seminal vesicle development(GO:0061107) |
2.7 | 16.2 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
2.7 | 13.3 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
2.6 | 26.5 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
2.6 | 21.1 | GO:0015693 | magnesium ion transport(GO:0015693) |
2.6 | 10.5 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
2.6 | 28.8 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
2.6 | 5.2 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
2.6 | 10.4 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
2.6 | 2.6 | GO:0060369 | positive regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060369) |
2.6 | 28.1 | GO:0099638 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) endosome to plasma membrane protein transport(GO:0099638) neurotransmitter receptor transport, endosome to plasma membrane(GO:0099639) |
2.6 | 10.2 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
2.5 | 10.0 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
2.5 | 7.5 | GO:1901895 | negative regulation of calcium-transporting ATPase activity(GO:1901895) |
2.5 | 9.9 | GO:0003335 | corneocyte development(GO:0003335) |
2.5 | 24.6 | GO:0006600 | creatine metabolic process(GO:0006600) |
2.4 | 9.8 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
2.4 | 22.0 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
2.4 | 19.5 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
2.4 | 12.2 | GO:1901091 | regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
2.4 | 4.9 | GO:0032571 | response to vitamin K(GO:0032571) |
2.4 | 338.8 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
2.4 | 9.7 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
2.4 | 7.2 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
2.4 | 4.8 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
2.4 | 4.8 | GO:0002436 | immune complex clearance(GO:0002434) immune complex clearance by monocytes and macrophages(GO:0002436) regulation of immune complex clearance by monocytes and macrophages(GO:0090264) |
2.4 | 7.2 | GO:0002276 | basophil activation involved in immune response(GO:0002276) |
2.4 | 7.2 | GO:1902490 | regulation of sperm capacitation(GO:1902490) |
2.4 | 26.2 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
2.4 | 9.5 | GO:0018094 | protein polyglycylation(GO:0018094) |
2.4 | 7.1 | GO:0046208 | spermine catabolic process(GO:0046208) |
2.3 | 11.7 | GO:0002865 | negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) |
2.3 | 7.0 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) establishment of meiotic spindle localization(GO:0051295) |
2.3 | 27.9 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
2.3 | 11.6 | GO:0097017 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) renal protein absorption(GO:0097017) protein processing in phagocytic vesicle(GO:1900756) regulation of plasma membrane raft polarization(GO:1903906) regulation of protein processing in phagocytic vesicle(GO:1903921) positive regulation of protein processing in phagocytic vesicle(GO:1903923) |
2.3 | 6.9 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) negative regulation of DNA catabolic process(GO:1903625) regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
2.3 | 27.7 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
2.3 | 16.1 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
2.3 | 6.9 | GO:0002522 | leukocyte migration involved in immune response(GO:0002522) |
2.3 | 36.6 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
2.3 | 13.6 | GO:2000479 | regulation of cAMP-dependent protein kinase activity(GO:2000479) negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
2.3 | 11.3 | GO:0006543 | glutamine catabolic process(GO:0006543) |
2.3 | 9.1 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
2.3 | 4.5 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
2.2 | 6.7 | GO:0001826 | inner cell mass cell differentiation(GO:0001826) |
2.2 | 6.7 | GO:0015793 | glycerol transport(GO:0015793) |
2.2 | 6.7 | GO:0048104 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
2.2 | 35.3 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
2.2 | 24.3 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
2.2 | 2.2 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
2.2 | 10.9 | GO:0046968 | peptide antigen transport(GO:0046968) |
2.2 | 6.6 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
2.2 | 6.5 | GO:0070105 | positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
2.2 | 17.3 | GO:0021978 | telencephalon regionalization(GO:0021978) |
2.2 | 15.1 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
2.1 | 15.0 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
2.1 | 6.4 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
2.1 | 8.5 | GO:0002215 | defense response to nematode(GO:0002215) |
2.1 | 2.1 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
2.1 | 8.4 | GO:0035935 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
2.1 | 10.4 | GO:0016322 | neuron remodeling(GO:0016322) |
2.1 | 14.6 | GO:0032119 | sequestering of zinc ion(GO:0032119) |
2.1 | 60.1 | GO:1903861 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
2.1 | 29.0 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
2.1 | 30.9 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
2.0 | 6.1 | GO:2000417 | negative regulation of eosinophil migration(GO:2000417) |
2.0 | 21.9 | GO:0045008 | depyrimidination(GO:0045008) |
2.0 | 8.0 | GO:1902613 | regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
2.0 | 25.8 | GO:0003351 | epithelial cilium movement(GO:0003351) |
2.0 | 3.9 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
2.0 | 5.9 | GO:0051102 | DNA ligation involved in DNA recombination(GO:0051102) |
2.0 | 15.6 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
1.9 | 11.6 | GO:0018343 | protein farnesylation(GO:0018343) |
1.9 | 21.0 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
1.9 | 1.9 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
1.9 | 5.7 | GO:0032223 | negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
1.9 | 126.7 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
1.9 | 22.3 | GO:0070327 | thyroid hormone transport(GO:0070327) |
1.8 | 7.4 | GO:0002086 | diaphragm contraction(GO:0002086) |
1.8 | 7.4 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
1.8 | 23.9 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
1.8 | 7.3 | GO:0007525 | somatic muscle development(GO:0007525) |
1.8 | 7.3 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
1.8 | 18.1 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
1.8 | 14.5 | GO:0001675 | acrosome assembly(GO:0001675) |
1.8 | 5.3 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
1.8 | 19.4 | GO:0021513 | spinal cord dorsal/ventral patterning(GO:0021513) |
1.8 | 5.3 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
1.8 | 7.0 | GO:0032782 | bile acid secretion(GO:0032782) |
1.7 | 8.7 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
1.7 | 5.2 | GO:2001166 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
1.7 | 8.6 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
1.7 | 17.2 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
1.7 | 12.0 | GO:0001955 | blood vessel maturation(GO:0001955) |
1.7 | 3.4 | GO:1902219 | regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
1.7 | 10.1 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
1.7 | 5.0 | GO:0032776 | DNA methylation on cytosine(GO:0032776) |
1.7 | 3.4 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) |
1.7 | 6.7 | GO:0003343 | proepicardium development(GO:0003342) septum transversum development(GO:0003343) |
1.7 | 8.3 | GO:0001501 | skeletal system development(GO:0001501) |
1.7 | 6.6 | GO:0034959 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
1.7 | 9.9 | GO:0032418 | lysosome localization(GO:0032418) |
1.7 | 6.6 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
1.7 | 1.7 | GO:0060433 | bronchus development(GO:0060433) |
1.6 | 1.6 | GO:0043366 | beta selection(GO:0043366) |
1.6 | 4.9 | GO:0009437 | carnitine metabolic process(GO:0009437) |
1.6 | 6.5 | GO:0048698 | negative regulation of collateral sprouting in absence of injury(GO:0048698) |
1.6 | 8.1 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
1.6 | 41.9 | GO:0097503 | sialylation(GO:0097503) |
1.6 | 4.8 | GO:1902995 | regulation of phospholipid efflux(GO:1902994) positive regulation of phospholipid efflux(GO:1902995) |
1.6 | 23.9 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
1.6 | 22.3 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
1.6 | 7.9 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
1.6 | 4.7 | GO:2000295 | regulation of hydrogen peroxide catabolic process(GO:2000295) |
1.6 | 6.3 | GO:0035640 | exploration behavior(GO:0035640) |
1.6 | 4.7 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
1.5 | 4.6 | GO:0021938 | ventral midline development(GO:0007418) cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
1.5 | 13.6 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
1.5 | 15.0 | GO:0032429 | regulation of phospholipase A2 activity(GO:0032429) |
1.5 | 7.5 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
1.5 | 3.0 | GO:2001190 | positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001190) |
1.5 | 4.5 | GO:0003160 | endocardium morphogenesis(GO:0003160) stem cell fate commitment(GO:0048865) endocardium formation(GO:0060214) |
1.5 | 42.7 | GO:0045687 | positive regulation of glial cell differentiation(GO:0045687) |
1.5 | 7.3 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
1.5 | 7.3 | GO:1903146 | regulation of mitophagy(GO:1903146) |
1.5 | 17.6 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
1.5 | 2.9 | GO:0060372 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) |
1.5 | 2.9 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
1.5 | 11.6 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
1.5 | 2.9 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
1.4 | 50.5 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
1.4 | 4.3 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
1.4 | 21.5 | GO:0048490 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
1.4 | 2.9 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
1.4 | 15.6 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
1.4 | 9.9 | GO:0007256 | activation of JNKK activity(GO:0007256) |
1.4 | 12.7 | GO:0002778 | antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
1.4 | 22.4 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
1.4 | 5.6 | GO:0072402 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
1.4 | 7.0 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
1.4 | 8.3 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
1.4 | 2.8 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
1.4 | 8.3 | GO:1903301 | fructose 2,6-bisphosphate metabolic process(GO:0006003) positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
1.4 | 15.2 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
1.4 | 6.9 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
1.4 | 17.8 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
1.4 | 34.1 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
1.4 | 2.7 | GO:0060048 | cardiac muscle contraction(GO:0060048) |
1.4 | 8.2 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
1.4 | 17.7 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
1.4 | 6.8 | GO:0015855 | pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
1.4 | 21.7 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
1.4 | 2.7 | GO:1903526 | negative regulation of membrane tubulation(GO:1903526) |
1.4 | 19.0 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
1.3 | 14.8 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
1.3 | 4.0 | GO:0090237 | regulation of arachidonic acid secretion(GO:0090237) |
1.3 | 10.7 | GO:0070995 | NADPH oxidation(GO:0070995) |
1.3 | 1.3 | GO:0010873 | positive regulation of cholesterol esterification(GO:0010873) |
1.3 | 29.3 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
1.3 | 4.0 | GO:0003220 | left ventricular cardiac muscle tissue morphogenesis(GO:0003220) cell proliferation involved in heart valve morphogenesis(GO:0003249) regulation of cell proliferation involved in heart valve morphogenesis(GO:0003250) sebaceous gland development(GO:0048733) formation of anatomical boundary(GO:0048859) cell proliferation involved in heart valve development(GO:2000793) |
1.3 | 5.3 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
1.3 | 10.5 | GO:0034351 | regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) positive regulation of B cell receptor signaling pathway(GO:0050861) |
1.3 | 11.8 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
1.3 | 3.9 | GO:1901837 | negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
1.3 | 3.9 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
1.3 | 11.7 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
1.3 | 7.8 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
1.3 | 41.1 | GO:1901685 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
1.3 | 9.0 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
1.3 | 5.1 | GO:0015942 | folic acid-containing compound catabolic process(GO:0009397) formate metabolic process(GO:0015942) pteridine-containing compound catabolic process(GO:0042560) |
1.3 | 21.7 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
1.3 | 5.1 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
1.2 | 20.0 | GO:0006670 | sphingosine metabolic process(GO:0006670) diol metabolic process(GO:0034311) |
1.2 | 12.5 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
1.2 | 15.0 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
1.2 | 5.0 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
1.2 | 28.5 | GO:0002377 | immunoglobulin production(GO:0002377) |
1.2 | 7.4 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
1.2 | 2.4 | GO:1902723 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
1.2 | 3.7 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
1.2 | 4.9 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
1.2 | 19.4 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
1.2 | 8.5 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
1.2 | 3.6 | GO:2000537 | regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
1.2 | 6.0 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
1.2 | 3.6 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
1.2 | 3.6 | GO:1901889 | negative regulation of cell junction assembly(GO:1901889) |
1.2 | 23.8 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
1.2 | 3.5 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
1.2 | 8.2 | GO:0006489 | dolichyl diphosphate biosynthetic process(GO:0006489) dolichyl diphosphate metabolic process(GO:0046465) |
1.2 | 37.7 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
1.2 | 14.0 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
1.2 | 5.8 | GO:1904098 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
1.2 | 10.4 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
1.2 | 13.8 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
1.2 | 2.3 | GO:0060061 | Spemann organizer formation(GO:0060061) |
1.2 | 9.2 | GO:0002455 | humoral immune response mediated by circulating immunoglobulin(GO:0002455) |
1.1 | 4.6 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
1.1 | 11.4 | GO:0006473 | protein acetylation(GO:0006473) |
1.1 | 3.4 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
1.1 | 5.7 | GO:0030035 | microspike assembly(GO:0030035) |
1.1 | 3.4 | GO:1901053 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
1.1 | 6.8 | GO:0036101 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
1.1 | 1.1 | GO:0072711 | cellular response to hydroxyurea(GO:0072711) |
1.1 | 6.8 | GO:0006857 | oligopeptide transport(GO:0006857) |
1.1 | 3.4 | GO:1904300 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
1.1 | 5.6 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
1.1 | 2.2 | GO:0060070 | canonical Wnt signaling pathway(GO:0060070) |
1.1 | 3.4 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
1.1 | 4.5 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
1.1 | 3.4 | GO:0032474 | otolith morphogenesis(GO:0032474) |
1.1 | 3.3 | GO:0097460 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
1.1 | 2.2 | GO:1900158 | negative regulation of osteoclast proliferation(GO:0090291) negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
1.1 | 10.0 | GO:1904180 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
1.1 | 12.2 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
1.1 | 6.7 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
1.1 | 14.4 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
1.1 | 3.3 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
1.1 | 19.9 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
1.1 | 5.5 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
1.1 | 45.9 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
1.1 | 9.8 | GO:0097012 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
1.1 | 7.6 | GO:0014877 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
1.1 | 8.6 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
1.1 | 5.4 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
1.1 | 4.3 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
1.1 | 3.2 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
1.1 | 4.2 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
1.1 | 21.1 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
1.0 | 3.1 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
1.0 | 11.5 | GO:0021988 | olfactory bulb development(GO:0021772) olfactory lobe development(GO:0021988) |
1.0 | 20.9 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
1.0 | 7.3 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
1.0 | 3.1 | GO:2000661 | positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
1.0 | 26.8 | GO:0071800 | podosome assembly(GO:0071800) |
1.0 | 7.2 | GO:0097354 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
1.0 | 10.2 | GO:0015889 | cobalamin transport(GO:0015889) |
1.0 | 10.1 | GO:0001759 | organ induction(GO:0001759) |
1.0 | 8.9 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
1.0 | 3.0 | GO:0019418 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
1.0 | 7.9 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
1.0 | 44.2 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
1.0 | 4.9 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
1.0 | 8.7 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) nucleoside triphosphate catabolic process(GO:0009143) |
1.0 | 12.6 | GO:0043306 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
1.0 | 5.8 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
1.0 | 50.9 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
1.0 | 5.7 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
1.0 | 5.7 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.9 | 3.7 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
0.9 | 2.8 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
0.9 | 1.9 | GO:0006258 | UDP-glucose catabolic process(GO:0006258) |
0.9 | 9.3 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.9 | 15.8 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.9 | 4.6 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.9 | 3.7 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.9 | 5.5 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.9 | 16.5 | GO:0097186 | amelogenesis(GO:0097186) |
0.9 | 2.7 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.9 | 8.1 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.9 | 8.0 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.9 | 8.0 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.9 | 0.9 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.9 | 18.6 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.9 | 0.9 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.9 | 4.4 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.9 | 7.8 | GO:0051712 | positive regulation of killing of cells of other organism(GO:0051712) |
0.9 | 12.0 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.9 | 50.5 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.9 | 6.8 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.9 | 20.5 | GO:0014072 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.8 | 17.0 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.8 | 19.4 | GO:0034204 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.8 | 5.1 | GO:0001554 | luteolysis(GO:0001554) |
0.8 | 5.0 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.8 | 5.0 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.8 | 4.1 | GO:0003322 | pancreatic A cell development(GO:0003322) |
0.8 | 2.5 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
0.8 | 2.5 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
0.8 | 5.7 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
0.8 | 5.7 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.8 | 1.6 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.8 | 8.1 | GO:0010265 | SCF complex assembly(GO:0010265) |
0.8 | 1.6 | GO:0021936 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
0.8 | 4.8 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.8 | 6.4 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.8 | 4.8 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.8 | 9.6 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.8 | 5.5 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.8 | 7.1 | GO:0015074 | DNA integration(GO:0015074) |
0.8 | 47.0 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.8 | 1.6 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.8 | 7.7 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.8 | 4.6 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.8 | 6.9 | GO:0006111 | regulation of gluconeogenesis(GO:0006111) |
0.8 | 14.5 | GO:0043949 | regulation of cAMP-mediated signaling(GO:0043949) |
0.8 | 2.3 | GO:0002818 | intracellular defense response(GO:0002818) |
0.8 | 5.3 | GO:0071028 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.8 | 4.5 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.8 | 9.8 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.7 | 3.7 | GO:0002438 | acute inflammatory response to antigenic stimulus(GO:0002438) |
0.7 | 6.6 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
0.7 | 5.9 | GO:0042745 | circadian sleep/wake cycle process(GO:0022410) circadian sleep/wake cycle(GO:0042745) regulation of circadian sleep/wake cycle(GO:0042749) regulation of circadian sleep/wake cycle, sleep(GO:0045187) circadian sleep/wake cycle, sleep(GO:0050802) |
0.7 | 3.7 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.7 | 1.5 | GO:2000354 | response to prolactin(GO:1990637) regulation of ovarian follicle development(GO:2000354) |
0.7 | 1.4 | GO:0060042 | retina morphogenesis in camera-type eye(GO:0060042) |
0.7 | 4.3 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
0.7 | 11.4 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.7 | 12.0 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
0.7 | 4.9 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
0.7 | 4.2 | GO:0051450 | myoblast proliferation(GO:0051450) |
0.7 | 5.6 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.7 | 17.4 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.7 | 4.9 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
0.7 | 15.1 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
0.7 | 3.4 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.7 | 9.5 | GO:0070977 | bone maturation(GO:0070977) |
0.7 | 4.1 | GO:1903845 | negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
0.7 | 7.4 | GO:0060612 | adipose tissue development(GO:0060612) |
0.7 | 65.2 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.7 | 2.0 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.7 | 54.3 | GO:0007041 | lysosomal transport(GO:0007041) |
0.7 | 6.6 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.7 | 4.0 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.7 | 15.2 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
0.7 | 7.9 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
0.7 | 3.9 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.7 | 3.9 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.7 | 16.3 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.7 | 10.4 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.6 | 3.2 | GO:0060088 | auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) |
0.6 | 7.7 | GO:0006705 | mineralocorticoid biosynthetic process(GO:0006705) mineralocorticoid metabolic process(GO:0008212) |
0.6 | 6.4 | GO:0097435 | fibril organization(GO:0097435) |
0.6 | 2.6 | GO:0046822 | regulation of nucleocytoplasmic transport(GO:0046822) |
0.6 | 4.5 | GO:0021924 | cell proliferation in hindbrain(GO:0021534) cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
0.6 | 1.9 | GO:0048505 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
0.6 | 11.9 | GO:0007618 | mating(GO:0007618) |
0.6 | 1.9 | GO:0001555 | oocyte growth(GO:0001555) |
0.6 | 16.2 | GO:0098743 | cell aggregation(GO:0098743) |
0.6 | 10.0 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
0.6 | 0.6 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.6 | 29.6 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
0.6 | 9.2 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.6 | 2.5 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.6 | 6.1 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.6 | 17.6 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.6 | 3.0 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.6 | 3.0 | GO:1900151 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.6 | 4.8 | GO:0046415 | urate metabolic process(GO:0046415) |
0.6 | 11.9 | GO:0051567 | histone H3-K9 methylation(GO:0051567) |
0.6 | 1.8 | GO:0071688 | myosin filament organization(GO:0031033) myosin filament assembly(GO:0031034) striated muscle myosin thick filament assembly(GO:0071688) |
0.6 | 1.8 | GO:0080009 | mRNA methylation(GO:0080009) |
0.6 | 5.3 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.6 | 23.0 | GO:0051646 | mitochondrion localization(GO:0051646) |
0.6 | 2.9 | GO:1902659 | regulation of glucose mediated signaling pathway(GO:1902659) |
0.6 | 5.2 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.6 | 8.7 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
0.6 | 5.8 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.6 | 33.7 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.6 | 1.2 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.6 | 4.1 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.6 | 3.5 | GO:0001867 | complement activation, lectin pathway(GO:0001867) recognition of apoptotic cell(GO:0043654) |
0.6 | 2.3 | GO:0070942 | neutrophil mediated cytotoxicity(GO:0070942) neutrophil mediated killing of symbiont cell(GO:0070943) neutrophil mediated killing of bacterium(GO:0070944) |
0.6 | 7.3 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.6 | 9.6 | GO:0006152 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.6 | 5.0 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.6 | 14.3 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
0.5 | 4.9 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.5 | 1.6 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.5 | 1.6 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.5 | 7.1 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.5 | 3.8 | GO:0050680 | negative regulation of epithelial cell proliferation(GO:0050680) |
0.5 | 2.7 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.5 | 2.7 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.5 | 14.5 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.5 | 3.7 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
0.5 | 5.3 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.5 | 2.6 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.5 | 4.2 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.5 | 4.6 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.5 | 2.6 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
0.5 | 2.6 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.5 | 5.1 | GO:0007340 | acrosome reaction(GO:0007340) |
0.5 | 12.5 | GO:0015695 | organic cation transport(GO:0015695) |
0.5 | 5.5 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
0.5 | 2.0 | GO:0046643 | regulation of gamma-delta T cell activation(GO:0046643) |
0.5 | 3.9 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.5 | 9.8 | GO:0019722 | calcium-mediated signaling(GO:0019722) |
0.5 | 17.6 | GO:0051145 | smooth muscle cell differentiation(GO:0051145) |
0.5 | 1.5 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.5 | 3.9 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.5 | 1.4 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
0.5 | 7.7 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.5 | 3.8 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.5 | 8.1 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.5 | 9.1 | GO:0033280 | response to vitamin D(GO:0033280) |
0.5 | 9.9 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.5 | 0.9 | GO:2000543 | positive regulation of gastrulation(GO:2000543) |
0.5 | 1.4 | GO:1990822 | basic amino acid transmembrane transport(GO:1990822) |
0.5 | 7.5 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
0.5 | 5.6 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.5 | 1.9 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.5 | 7.4 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.5 | 7.4 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.5 | 8.3 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.5 | 1.4 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.5 | 2.3 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.5 | 5.0 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.5 | 5.0 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.5 | 5.0 | GO:0002042 | cell migration involved in sprouting angiogenesis(GO:0002042) |
0.5 | 4.5 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.5 | 12.6 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.4 | 2.2 | GO:0015811 | L-cystine transport(GO:0015811) |
0.4 | 6.3 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.4 | 4.5 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.4 | 1.8 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.4 | 7.0 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.4 | 2.6 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.4 | 6.1 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.4 | 2.6 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.4 | 7.4 | GO:0042044 | water transport(GO:0006833) fluid transport(GO:0042044) |
0.4 | 4.3 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.4 | 3.9 | GO:0014002 | astrocyte development(GO:0014002) |
0.4 | 0.9 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.4 | 4.3 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.4 | 6.8 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.4 | 7.2 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.4 | 4.6 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.4 | 1.3 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.4 | 7.5 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.4 | 6.2 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.4 | 7.8 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.4 | 13.8 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.4 | 12.1 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.4 | 2.0 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.4 | 2.4 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.4 | 1.6 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.4 | 5.2 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.4 | 0.8 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.4 | 18.7 | GO:0042102 | positive regulation of T cell proliferation(GO:0042102) |
0.4 | 3.9 | GO:0060850 | regulation of transcription involved in cell fate commitment(GO:0060850) |
0.4 | 6.6 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.4 | 2.7 | GO:0035898 | parathyroid hormone secretion(GO:0035898) post-embryonic body morphogenesis(GO:0040032) regulation of parathyroid hormone secretion(GO:2000828) |
0.4 | 3.8 | GO:2000615 | histone H3-K9 acetylation(GO:0043970) regulation of histone H3-K9 acetylation(GO:2000615) |
0.4 | 5.8 | GO:0021983 | pituitary gland development(GO:0021983) |
0.4 | 6.1 | GO:0032288 | myelin assembly(GO:0032288) |
0.4 | 4.5 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.4 | 1.5 | GO:0032228 | regulation of synaptic transmission, GABAergic(GO:0032228) |
0.4 | 1.1 | GO:0010863 | positive regulation of phospholipase C activity(GO:0010863) |
0.4 | 2.6 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.4 | 2.6 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.4 | 7.2 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.4 | 4.7 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
0.4 | 2.5 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.3 | 4.9 | GO:1904886 | beta-catenin destruction complex disassembly(GO:1904886) |
0.3 | 3.1 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.3 | 1.7 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
0.3 | 5.8 | GO:0003254 | regulation of membrane depolarization(GO:0003254) |
0.3 | 4.8 | GO:0048024 | regulation of mRNA splicing, via spliceosome(GO:0048024) |
0.3 | 3.0 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.3 | 11.4 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.3 | 2.3 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.3 | 7.2 | GO:0050808 | synapse organization(GO:0050808) |
0.3 | 2.3 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.3 | 1.9 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.3 | 3.8 | GO:0014047 | glutamate secretion(GO:0014047) |
0.3 | 0.6 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.3 | 1.9 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.3 | 3.5 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.3 | 3.8 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.3 | 1.9 | GO:0045006 | DNA deamination(GO:0045006) DNA cytosine deamination(GO:0070383) |
0.3 | 5.0 | GO:0031018 | endocrine pancreas development(GO:0031018) |
0.3 | 3.1 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.3 | 4.7 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.3 | 7.4 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.3 | 1.5 | GO:0048665 | neuron fate specification(GO:0048665) |
0.3 | 8.7 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
0.3 | 3.0 | GO:0007512 | adult heart development(GO:0007512) |
0.3 | 2.1 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.3 | 3.2 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.3 | 12.6 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.3 | 6.4 | GO:0006895 | Golgi to endosome transport(GO:0006895) Golgi to vacuole transport(GO:0006896) |
0.3 | 0.6 | GO:0072553 | terminal button organization(GO:0072553) |
0.3 | 2.3 | GO:0007351 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.3 | 2.0 | GO:0098703 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
0.3 | 12.0 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.3 | 10.0 | GO:0098760 | interleukin-7-mediated signaling pathway(GO:0038111) response to interleukin-7(GO:0098760) cellular response to interleukin-7(GO:0098761) |
0.3 | 4.8 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.3 | 4.2 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.3 | 17.4 | GO:0006400 | tRNA modification(GO:0006400) |
0.3 | 3.6 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.3 | 2.2 | GO:1903019 | negative regulation of glycoprotein biosynthetic process(GO:0010561) negative regulation of glycoprotein metabolic process(GO:1903019) |
0.3 | 14.5 | GO:0050806 | positive regulation of synaptic transmission(GO:0050806) |
0.3 | 11.1 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.3 | 1.6 | GO:0048265 | response to pain(GO:0048265) |
0.3 | 7.4 | GO:0033077 | T cell differentiation in thymus(GO:0033077) thymocyte aggregation(GO:0071594) |
0.3 | 4.4 | GO:0042461 | photoreceptor cell development(GO:0042461) |
0.3 | 0.3 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.3 | 6.5 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.3 | 6.2 | GO:0033198 | response to ATP(GO:0033198) |
0.3 | 5.1 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.3 | 4.0 | GO:0018105 | peptidyl-serine phosphorylation(GO:0018105) |
0.2 | 2.0 | GO:0016180 | snRNA processing(GO:0016180) |
0.2 | 42.7 | GO:0043401 | steroid hormone mediated signaling pathway(GO:0043401) |
0.2 | 7.9 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.2 | 3.4 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.2 | 2.4 | GO:0016125 | sterol metabolic process(GO:0016125) |
0.2 | 2.4 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.2 | 0.7 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.2 | 1.7 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.2 | 14.7 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.2 | 17.3 | GO:0038096 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
0.2 | 30.2 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.2 | 1.6 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.2 | 1.9 | GO:0015868 | purine nucleotide transport(GO:0015865) purine ribonucleotide transport(GO:0015868) |
0.2 | 1.6 | GO:0050707 | regulation of cytokine secretion(GO:0050707) |
0.2 | 0.9 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.2 | 1.1 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.2 | 8.9 | GO:0046785 | microtubule polymerization(GO:0046785) |
0.2 | 1.4 | GO:0045023 | G0 to G1 transition(GO:0045023) |
0.2 | 5.0 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.2 | 0.4 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
0.2 | 2.5 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
0.2 | 13.5 | GO:0007286 | spermatid development(GO:0007286) |
0.2 | 2.5 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.2 | 1.9 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.2 | 4.7 | GO:0019233 | sensory perception of pain(GO:0019233) |
0.2 | 1.6 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.2 | 17.7 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.2 | 0.6 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) negative regulation of cell cycle G2/M phase transition(GO:1902750) |
0.2 | 3.2 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.2 | 0.4 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.2 | 1.1 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.2 | 1.6 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.2 | 3.0 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.2 | 5.6 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.2 | 2.1 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.2 | 2.8 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.2 | 4.3 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) |
0.2 | 0.3 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.2 | 1.9 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
0.2 | 2.0 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.2 | 0.6 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.2 | 0.2 | GO:0048368 | determination of left/right asymmetry in lateral mesoderm(GO:0003140) nodal signaling pathway involved in determination of left/right asymmetry(GO:0038107) lateral mesoderm development(GO:0048368) regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry(GO:1900094) nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900164) |
0.2 | 1.9 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.2 | 4.8 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.2 | 5.7 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.2 | 2.4 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.1 | 15.2 | GO:0007623 | circadian rhythm(GO:0007623) |
0.1 | 19.9 | GO:0046578 | regulation of Ras protein signal transduction(GO:0046578) |
0.1 | 3.4 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.1 | 18.0 | GO:0050953 | visual perception(GO:0007601) sensory perception of light stimulus(GO:0050953) |
0.1 | 6.2 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.1 | 2.5 | GO:0060348 | bone development(GO:0060348) |
0.1 | 0.8 | GO:0043586 | tongue development(GO:0043586) |
0.1 | 2.1 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.1 | 1.0 | GO:0097264 | self proteolysis(GO:0097264) |
0.1 | 0.7 | GO:0003184 | pulmonary valve development(GO:0003177) pulmonary valve morphogenesis(GO:0003184) |
0.1 | 2.0 | GO:0031110 | regulation of microtubule polymerization or depolymerization(GO:0031110) |
0.1 | 0.7 | GO:0035315 | hair cell differentiation(GO:0035315) |
0.1 | 1.0 | GO:0015871 | choline transport(GO:0015871) |
0.1 | 1.3 | GO:0009880 | embryonic pattern specification(GO:0009880) |
0.1 | 0.3 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) negative regulation of muscle hyperplasia(GO:0014740) |
0.1 | 0.5 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) |
0.1 | 2.2 | GO:0008016 | regulation of heart contraction(GO:0008016) |
0.1 | 4.2 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 0.8 | GO:0048593 | camera-type eye morphogenesis(GO:0048593) |
0.1 | 1.7 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.1 | 1.4 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.1 | 0.8 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 1.3 | GO:0001764 | neuron migration(GO:0001764) |
0.1 | 2.4 | GO:0070498 | interleukin-1-mediated signaling pathway(GO:0070498) |
0.1 | 0.5 | GO:0030038 | contractile actin filament bundle assembly(GO:0030038) stress fiber assembly(GO:0043149) |
0.1 | 1.1 | GO:0007141 | male meiosis I(GO:0007141) |
0.1 | 0.4 | GO:0044351 | macropinocytosis(GO:0044351) |
0.1 | 0.3 | GO:0045144 | meiotic sister chromatid segregation(GO:0045144) |
0.1 | 2.3 | GO:0008286 | insulin receptor signaling pathway(GO:0008286) |
0.1 | 0.5 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.1 | 0.2 | GO:0016999 | antibiotic metabolic process(GO:0016999) |
0.1 | 4.3 | GO:0010833 | telomere maintenance via telomere lengthening(GO:0010833) |
0.1 | 1.8 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.1 | 0.9 | GO:0006636 | unsaturated fatty acid biosynthetic process(GO:0006636) |
0.1 | 1.8 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
0.1 | 2.7 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.1 | 2.5 | GO:0018210 | peptidyl-threonine phosphorylation(GO:0018107) peptidyl-threonine modification(GO:0018210) |
0.1 | 1.9 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
0.1 | 1.0 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.1 | 2.6 | GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
0.1 | 1.8 | GO:0061178 | regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061178) |
0.1 | 0.6 | GO:0070873 | regulation of glycogen metabolic process(GO:0070873) |
0.1 | 0.6 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.1 | 1.3 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 0.3 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.0 | 0.3 | GO:0032094 | response to food(GO:0032094) |
0.0 | 0.6 | GO:0010812 | negative regulation of cell-substrate adhesion(GO:0010812) |
0.0 | 0.2 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.0 | 0.2 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.0 | 0.1 | GO:0042791 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
0.0 | 0.1 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.0 | 0.5 | GO:0006968 | cellular defense response(GO:0006968) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
13.4 | 40.3 | GO:0071748 | IgA immunoglobulin complex(GO:0071745) IgA immunoglobulin complex, circulating(GO:0071746) monomeric IgA immunoglobulin complex(GO:0071748) polymeric IgA immunoglobulin complex(GO:0071749) secretory IgA immunoglobulin complex(GO:0071751) |
10.8 | 172.5 | GO:0097512 | cardiac myofibril(GO:0097512) |
9.2 | 46.2 | GO:0045298 | tubulin complex(GO:0045298) |
8.6 | 25.7 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
8.1 | 56.8 | GO:0019815 | B cell receptor complex(GO:0019815) |
7.9 | 7.9 | GO:0097542 | ciliary tip(GO:0097542) |
7.5 | 37.3 | GO:0005602 | complement component C1 complex(GO:0005602) |
7.0 | 20.9 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
6.7 | 53.5 | GO:0060203 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
5.9 | 29.5 | GO:0010370 | perinucleolar chromocenter(GO:0010370) |
5.2 | 103.3 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
5.2 | 41.3 | GO:0045179 | apical cortex(GO:0045179) |
5.0 | 15.1 | GO:0097453 | mesaxon(GO:0097453) ensheathing process(GO:1990015) |
4.8 | 19.3 | GO:1990745 | EARP complex(GO:1990745) |
4.8 | 14.4 | GO:0031251 | PAN complex(GO:0031251) |
4.7 | 37.8 | GO:0098845 | postsynaptic endosome(GO:0098845) |
4.6 | 18.6 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
4.5 | 22.3 | GO:0034688 | integrin alphaM-beta2 complex(GO:0034688) |
4.3 | 90.4 | GO:0042613 | MHC class II protein complex(GO:0042613) |
4.3 | 12.8 | GO:0020005 | symbiont-containing vacuole(GO:0020003) symbiont-containing vacuole membrane(GO:0020005) |
3.6 | 14.6 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
3.6 | 21.7 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
3.5 | 17.7 | GO:0005899 | insulin receptor complex(GO:0005899) |
3.4 | 13.6 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
3.3 | 33.3 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
3.3 | 9.8 | GO:0031515 | tRNA (m1A) methyltransferase complex(GO:0031515) |
3.3 | 9.8 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
3.2 | 31.9 | GO:0097427 | microtubule bundle(GO:0097427) |
3.1 | 21.6 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
3.1 | 12.2 | GO:0032044 | DSIF complex(GO:0032044) |
2.7 | 127.4 | GO:0019814 | immunoglobulin complex(GO:0019814) immunoglobulin complex, circulating(GO:0042571) |
2.7 | 8.1 | GO:0036025 | protein C inhibitor-TMPRSS7 complex(GO:0036024) protein C inhibitor-TMPRSS11E complex(GO:0036025) protein C inhibitor-PLAT complex(GO:0036026) protein C inhibitor-PLAU complex(GO:0036027) protein C inhibitor-thrombin complex(GO:0036028) protein C inhibitor-KLK3 complex(GO:0036029) protein C inhibitor-plasma kallikrein complex(GO:0036030) serine protease inhibitor complex(GO:0097180) protein C inhibitor-coagulation factor V complex(GO:0097181) protein C inhibitor-coagulation factor Xa complex(GO:0097182) protein C inhibitor-coagulation factor XI complex(GO:0097183) |
2.7 | 13.4 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
2.7 | 10.7 | GO:1990031 | pinceau fiber(GO:1990031) |
2.5 | 15.3 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
2.5 | 52.8 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
2.5 | 12.3 | GO:1990761 | growth cone lamellipodium(GO:1990761) growth cone filopodium(GO:1990812) |
2.4 | 26.4 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
2.4 | 26.3 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
2.4 | 9.5 | GO:0032009 | early phagosome(GO:0032009) |
2.4 | 9.5 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
2.3 | 57.4 | GO:0071565 | nBAF complex(GO:0071565) |
2.3 | 31.8 | GO:0097227 | sperm annulus(GO:0097227) |
2.2 | 6.7 | GO:0060187 | cell pole(GO:0060187) |
2.2 | 11.1 | GO:0097513 | myosin II filament(GO:0097513) |
2.1 | 8.5 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
2.1 | 4.2 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
2.1 | 19.0 | GO:0005579 | membrane attack complex(GO:0005579) |
2.1 | 35.0 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
2.0 | 16.2 | GO:0036157 | outer dynein arm(GO:0036157) |
2.0 | 61.0 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
2.0 | 21.7 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
1.9 | 88.6 | GO:0048786 | presynaptic active zone(GO:0048786) |
1.9 | 38.4 | GO:0001891 | phagocytic cup(GO:0001891) |
1.9 | 21.0 | GO:0097433 | dense body(GO:0097433) |
1.9 | 5.7 | GO:0043159 | acrosomal matrix(GO:0043159) |
1.9 | 9.5 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
1.8 | 7.2 | GO:0035838 | growing cell tip(GO:0035838) |
1.8 | 7.2 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
1.8 | 5.3 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
1.7 | 30.9 | GO:0042101 | T cell receptor complex(GO:0042101) |
1.7 | 8.4 | GO:0089701 | U2AF(GO:0089701) |
1.7 | 13.3 | GO:0043196 | varicosity(GO:0043196) |
1.7 | 6.6 | GO:0031302 | intrinsic component of endosome membrane(GO:0031302) |
1.6 | 9.7 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
1.6 | 3.2 | GO:0033268 | node of Ranvier(GO:0033268) |
1.6 | 14.5 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
1.6 | 14.1 | GO:0016013 | syntrophin complex(GO:0016013) |
1.6 | 3.1 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
1.6 | 43.5 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
1.5 | 4.6 | GO:0070083 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
1.5 | 38.1 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
1.5 | 38.0 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
1.5 | 13.6 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
1.5 | 15.1 | GO:0005828 | kinetochore microtubule(GO:0005828) |
1.5 | 9.1 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
1.5 | 7.5 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
1.5 | 7.4 | GO:0034457 | Mpp10 complex(GO:0034457) |
1.4 | 11.6 | GO:0035976 | AP1 complex(GO:0035976) |
1.4 | 36.8 | GO:0031143 | pseudopodium(GO:0031143) |
1.4 | 8.4 | GO:1990769 | proximal neuron projection(GO:1990769) |
1.4 | 16.8 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
1.4 | 8.4 | GO:0000145 | exocyst(GO:0000145) |
1.4 | 20.9 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
1.4 | 5.6 | GO:0043293 | apoptosome(GO:0043293) |
1.4 | 5.5 | GO:0045160 | myosin I complex(GO:0045160) |
1.4 | 23.4 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
1.4 | 34.0 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
1.3 | 10.8 | GO:0033391 | chromatoid body(GO:0033391) |
1.3 | 15.9 | GO:0043083 | synaptic cleft(GO:0043083) |
1.3 | 15.8 | GO:0016461 | unconventional myosin complex(GO:0016461) |
1.3 | 13.1 | GO:0071953 | elastic fiber(GO:0071953) |
1.2 | 18.4 | GO:0000124 | SAGA complex(GO:0000124) |
1.2 | 14.7 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
1.2 | 12.0 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
1.2 | 8.4 | GO:0097209 | epidermal lamellar body(GO:0097209) |
1.2 | 8.3 | GO:0030061 | mitochondrial crista(GO:0030061) |
1.2 | 4.7 | GO:0097224 | sperm connecting piece(GO:0097224) |
1.2 | 5.9 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
1.2 | 4.7 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
1.1 | 49.4 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
1.1 | 13.3 | GO:0001741 | XY body(GO:0001741) |
1.1 | 21.0 | GO:0030673 | axolemma(GO:0030673) |
1.1 | 7.5 | GO:0060077 | inhibitory synapse(GO:0060077) |
1.1 | 15.9 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
1.1 | 5.3 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
1.0 | 9.4 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
1.0 | 159.9 | GO:0031225 | anchored component of membrane(GO:0031225) |
1.0 | 6.1 | GO:0032280 | symmetric synapse(GO:0032280) |
1.0 | 7.9 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
1.0 | 5.9 | GO:0032807 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) DNA ligase IV complex(GO:0032807) |
1.0 | 7.7 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
1.0 | 4.8 | GO:0032021 | NELF complex(GO:0032021) |
1.0 | 17.3 | GO:0005922 | connexon complex(GO:0005922) |
0.9 | 7.5 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.9 | 6.5 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.9 | 30.3 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.9 | 6.4 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.9 | 47.2 | GO:0001533 | cornified envelope(GO:0001533) |
0.9 | 1.8 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.8 | 2.5 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.8 | 9.1 | GO:0044447 | axoneme part(GO:0044447) |
0.8 | 4.1 | GO:1990393 | 3M complex(GO:1990393) |
0.8 | 2.5 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
0.8 | 20.3 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.8 | 13.9 | GO:0032590 | dendrite membrane(GO:0032590) |
0.8 | 3.0 | GO:0032010 | phagolysosome(GO:0032010) |
0.8 | 3.0 | GO:0031417 | NatC complex(GO:0031417) |
0.7 | 3.0 | GO:0038038 | G-protein coupled receptor homodimeric complex(GO:0038038) |
0.7 | 6.7 | GO:0043194 | axon initial segment(GO:0043194) |
0.7 | 13.3 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.7 | 10.9 | GO:0071437 | invadopodium(GO:0071437) |
0.7 | 6.4 | GO:0044194 | cytolytic granule(GO:0044194) |
0.7 | 12.7 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.7 | 2.1 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.7 | 76.5 | GO:0043679 | axon terminus(GO:0043679) |
0.7 | 4.8 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.7 | 15.1 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.7 | 8.9 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.7 | 6.8 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.7 | 63.2 | GO:0034705 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
0.7 | 4.0 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.7 | 4.6 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
0.7 | 23.5 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.7 | 3.9 | GO:0001740 | Barr body(GO:0001740) |
0.6 | 44.9 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.6 | 21.3 | GO:0008305 | integrin complex(GO:0008305) |
0.6 | 3.6 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.6 | 5.9 | GO:0042599 | lamellar body(GO:0042599) |
0.6 | 1.7 | GO:0016938 | kinesin I complex(GO:0016938) |
0.6 | 2.2 | GO:0060076 | excitatory synapse(GO:0060076) |
0.5 | 8.2 | GO:0005869 | dynactin complex(GO:0005869) |
0.5 | 3.8 | GO:0060091 | kinocilium(GO:0060091) |
0.5 | 15.1 | GO:0035861 | site of double-strand break(GO:0035861) |
0.5 | 3.6 | GO:0033269 | internode region of axon(GO:0033269) |
0.5 | 5.2 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.5 | 4.1 | GO:0000322 | storage vacuole(GO:0000322) |
0.5 | 117.7 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.5 | 3.4 | GO:0060170 | ciliary membrane(GO:0060170) |
0.5 | 3.3 | GO:0097486 | multivesicular body lumen(GO:0097486) |
0.5 | 4.6 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.5 | 5.5 | GO:0097440 | apical dendrite(GO:0097440) |
0.5 | 23.4 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.4 | 13.7 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.4 | 21.0 | GO:0031526 | brush border membrane(GO:0031526) |
0.4 | 3.1 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.4 | 5.6 | GO:0042588 | zymogen granule(GO:0042588) |
0.4 | 14.0 | GO:0034707 | chloride channel complex(GO:0034707) |
0.4 | 5.3 | GO:0097228 | sperm principal piece(GO:0097228) |
0.4 | 4.0 | GO:0042587 | glycogen granule(GO:0042587) |
0.4 | 8.0 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.4 | 12.9 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.4 | 6.1 | GO:0097225 | sperm midpiece(GO:0097225) |
0.4 | 2.2 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.4 | 25.2 | GO:0030426 | growth cone(GO:0030426) |
0.4 | 3.9 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.3 | 1.4 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.3 | 15.1 | GO:0097060 | synaptic membrane(GO:0097060) |
0.3 | 6.2 | GO:0005861 | troponin complex(GO:0005861) |
0.3 | 21.5 | GO:0031514 | motile cilium(GO:0031514) |
0.3 | 12.4 | GO:0016592 | mediator complex(GO:0016592) |
0.3 | 11.4 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.3 | 33.1 | GO:0055037 | recycling endosome(GO:0055037) |
0.3 | 2.6 | GO:0001739 | sex chromatin(GO:0001739) |
0.3 | 49.2 | GO:0098794 | postsynapse(GO:0098794) |
0.3 | 5.1 | GO:0042627 | chylomicron(GO:0042627) |
0.3 | 3.8 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.3 | 6.6 | GO:0051233 | spindle midzone(GO:0051233) |
0.3 | 20.3 | GO:0030424 | axon(GO:0030424) |
0.3 | 24.1 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.3 | 3.9 | GO:0036038 | MKS complex(GO:0036038) |
0.3 | 13.6 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.3 | 8.4 | GO:0043198 | dendritic shaft(GO:0043198) |
0.3 | 3.2 | GO:0001772 | immunological synapse(GO:0001772) |
0.3 | 12.7 | GO:0016235 | aggresome(GO:0016235) |
0.3 | 6.1 | GO:0005844 | polysome(GO:0005844) |
0.2 | 10.5 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.2 | 50.8 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.2 | 2.5 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.2 | 21.3 | GO:0030133 | transport vesicle(GO:0030133) |
0.2 | 2.7 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.2 | 4.9 | GO:0031904 | endosome lumen(GO:0031904) |
0.2 | 4.0 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.2 | 1.1 | GO:0097123 | cyclin A1-CDK2 complex(GO:0097123) |
0.2 | 2.0 | GO:0032039 | integrator complex(GO:0032039) |
0.2 | 2.1 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.2 | 0.4 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.2 | 1.1 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.2 | 1.4 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.2 | 17.3 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.2 | 11.8 | GO:0005796 | Golgi lumen(GO:0005796) |
0.2 | 4.5 | GO:1903293 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.1 | 3.1 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 396.4 | GO:0016021 | integral component of membrane(GO:0016021) |
0.1 | 6.7 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 2.0 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.1 | 2.9 | GO:0031201 | SNARE complex(GO:0031201) |
0.1 | 3.5 | GO:0005902 | microvillus(GO:0005902) |
0.1 | 0.3 | GO:0000818 | nuclear MIS12/MIND complex(GO:0000818) condensed chromosome inner kinetochore(GO:0000939) |
0.1 | 5.9 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 26.6 | GO:0045202 | synapse(GO:0045202) |
0.1 | 1.5 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 0.7 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.1 | 3.3 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.1 | 1.7 | GO:0090568 | nuclear transcriptional repressor complex(GO:0090568) |
0.1 | 1.4 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.0 | 0.1 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 41.9 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.2 | GO:0005771 | multivesicular body(GO:0005771) |
0.0 | 0.2 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.0 | 1.4 | GO:0032587 | ruffle membrane(GO:0032587) |
0.0 | 0.1 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
13.6 | 54.4 | GO:0032406 | MutLbeta complex binding(GO:0032406) MutSbeta complex binding(GO:0032408) |
11.7 | 70.4 | GO:0004522 | ribonuclease A activity(GO:0004522) |
11.4 | 34.1 | GO:0032093 | SAM domain binding(GO:0032093) |
10.7 | 42.6 | GO:0099609 | microtubule lateral binding(GO:0099609) |
8.9 | 71.4 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
8.8 | 44.0 | GO:0042289 | MHC class II protein binding(GO:0042289) |
8.6 | 51.7 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
8.6 | 25.8 | GO:0051139 | metal ion:proton antiporter activity(GO:0051139) |
8.4 | 25.1 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
7.6 | 30.2 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
7.5 | 22.4 | GO:0045174 | oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor(GO:0016672) glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
7.4 | 44.5 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
7.2 | 28.6 | GO:0035939 | microsatellite binding(GO:0035939) |
6.6 | 19.9 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
5.9 | 23.8 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
5.7 | 5.7 | GO:0042806 | fucose binding(GO:0042806) |
5.6 | 22.3 | GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor(GO:0016639) |
5.3 | 163.3 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
5.2 | 21.0 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
5.2 | 15.7 | GO:0008955 | peptidoglycan glycosyltransferase activity(GO:0008955) |
5.2 | 20.9 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
5.1 | 30.9 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
5.1 | 25.3 | GO:0001641 | group II metabotropic glutamate receptor activity(GO:0001641) |
5.0 | 25.0 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
5.0 | 19.8 | GO:0030226 | apolipoprotein receptor activity(GO:0030226) |
4.6 | 18.3 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
4.6 | 13.7 | GO:0035379 | carbon dioxide transmembrane transporter activity(GO:0035379) |
4.5 | 18.1 | GO:0016900 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
4.5 | 22.3 | GO:0052901 | polyamine oxidase activity(GO:0046592) spermine:oxygen oxidoreductase (spermidine-forming) activity(GO:0052901) |
4.5 | 22.3 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
4.4 | 13.2 | GO:0004960 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
4.4 | 17.6 | GO:1904492 | Ac-Asp-Glu binding(GO:1904492) tetrahydrofolyl-poly(glutamate) polymer binding(GO:1904493) |
4.2 | 12.7 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
4.2 | 37.8 | GO:0032051 | clathrin light chain binding(GO:0032051) |
4.1 | 12.2 | GO:1904599 | advanced glycation end-product binding(GO:1904599) |
4.0 | 20.2 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
4.0 | 12.1 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
4.0 | 16.0 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
4.0 | 27.7 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
3.9 | 23.5 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
3.9 | 11.7 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
3.9 | 15.6 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
3.9 | 15.5 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
3.8 | 26.5 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
3.8 | 15.1 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
3.8 | 15.1 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
3.7 | 18.5 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
3.7 | 18.5 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
3.7 | 11.0 | GO:0070051 | fibrinogen binding(GO:0070051) |
3.6 | 14.2 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
3.4 | 20.6 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
3.4 | 10.2 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
3.4 | 16.9 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
3.3 | 9.8 | GO:0016429 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
3.3 | 9.8 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
3.2 | 9.5 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
3.1 | 9.3 | GO:0004878 | complement component C5a receptor activity(GO:0004878) |
3.1 | 9.3 | GO:0004796 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
3.1 | 18.5 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
3.1 | 18.5 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
3.0 | 9.1 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
3.0 | 165.7 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
2.9 | 23.5 | GO:0004111 | creatine kinase activity(GO:0004111) |
2.9 | 52.5 | GO:0019864 | IgG binding(GO:0019864) |
2.8 | 5.7 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
2.8 | 8.5 | GO:0070052 | collagen V binding(GO:0070052) |
2.8 | 22.6 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
2.6 | 47.6 | GO:0043274 | phospholipase binding(GO:0043274) |
2.6 | 7.9 | GO:0004613 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
2.6 | 31.1 | GO:0032027 | myosin light chain binding(GO:0032027) |
2.6 | 12.9 | GO:0070905 | serine binding(GO:0070905) |
2.6 | 12.9 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
2.6 | 7.7 | GO:0004769 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) steroid delta-isomerase activity(GO:0004769) |
2.6 | 25.6 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
2.5 | 15.3 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
2.5 | 34.8 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
2.5 | 9.9 | GO:0017040 | ceramidase activity(GO:0017040) |
2.5 | 9.9 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
2.4 | 12.2 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
2.4 | 7.2 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
2.4 | 9.5 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
2.3 | 23.2 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
2.3 | 13.9 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
2.3 | 20.7 | GO:0008556 | potassium-transporting ATPase activity(GO:0008556) |
2.3 | 6.8 | GO:0015389 | pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
2.3 | 6.8 | GO:0052871 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) 20-hydroxy-leukotriene B4 omega oxidase activity(GO:0097258) 20-aldehyde-leukotriene B4 20-monooxygenase activity(GO:0097259) |
2.3 | 11.3 | GO:0004359 | glutaminase activity(GO:0004359) |
2.2 | 35.8 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
2.2 | 20.0 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
2.2 | 6.6 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
2.2 | 11.1 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
2.2 | 46.2 | GO:0031005 | filamin binding(GO:0031005) |
2.2 | 19.5 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
2.1 | 6.4 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
2.1 | 27.8 | GO:0030957 | Tat protein binding(GO:0030957) |
2.1 | 10.6 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
2.1 | 10.5 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
2.1 | 10.4 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
2.1 | 105.1 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
2.0 | 16.1 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
2.0 | 23.9 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
2.0 | 25.9 | GO:0033691 | sialic acid binding(GO:0033691) |
2.0 | 8.0 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
2.0 | 51.5 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
1.9 | 11.7 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
1.9 | 5.7 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
1.9 | 5.7 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
1.9 | 9.5 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
1.9 | 9.5 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
1.9 | 7.6 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
1.8 | 7.4 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
1.8 | 5.5 | GO:0052831 | inositol tetrakisphosphate 1-kinase activity(GO:0047325) inositol tetrakisphosphate kinase activity(GO:0051765) inositol-1,3,4-trisphosphate 6-kinase activity(GO:0052725) inositol-1,3,4-trisphosphate 5-kinase activity(GO:0052726) inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity(GO:0052825) inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity(GO:0052830) inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity(GO:0052831) inositol-3,4,6-trisphosphate 1-kinase activity(GO:0052835) |
1.8 | 11.0 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
1.8 | 9.1 | GO:0051373 | FATZ binding(GO:0051373) |
1.8 | 5.4 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
1.8 | 3.6 | GO:0008142 | oxysterol binding(GO:0008142) |
1.8 | 7.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
1.8 | 5.3 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
1.8 | 5.3 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
1.8 | 5.3 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
1.8 | 45.7 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
1.8 | 12.3 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
1.7 | 8.7 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
1.7 | 19.0 | GO:0048156 | tau protein binding(GO:0048156) |
1.7 | 5.1 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
1.7 | 22.1 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
1.7 | 8.4 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
1.7 | 5.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
1.7 | 18.4 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
1.7 | 6.7 | GO:0015254 | glycerol channel activity(GO:0015254) |
1.7 | 13.4 | GO:0047144 | 2-acylglycerol-3-phosphate O-acyltransferase activity(GO:0047144) |
1.7 | 5.0 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
1.7 | 5.0 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
1.7 | 6.7 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
1.7 | 6.6 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
1.6 | 80.5 | GO:0030507 | spectrin binding(GO:0030507) |
1.6 | 9.6 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
1.6 | 4.8 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
1.6 | 36.7 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
1.6 | 25.2 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
1.6 | 9.4 | GO:0004882 | androgen receptor activity(GO:0004882) |
1.6 | 29.8 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
1.6 | 11.0 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
1.6 | 17.2 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
1.6 | 7.8 | GO:0002046 | opsin binding(GO:0002046) |
1.5 | 46.4 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
1.5 | 4.6 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
1.5 | 38.0 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
1.5 | 6.1 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
1.5 | 13.6 | GO:0004985 | opioid receptor activity(GO:0004985) |
1.5 | 12.1 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
1.5 | 9.1 | GO:0051525 | NFAT protein binding(GO:0051525) |
1.5 | 25.4 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
1.5 | 5.9 | GO:0016499 | orexin receptor activity(GO:0016499) |
1.5 | 23.5 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
1.5 | 4.4 | GO:0050135 | NAD+ nucleosidase activity(GO:0003953) NAD(P)+ nucleosidase activity(GO:0050135) |
1.5 | 7.3 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
1.5 | 36.3 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
1.4 | 11.6 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
1.4 | 21.7 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
1.4 | 1.4 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
1.4 | 8.6 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
1.4 | 14.3 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
1.4 | 5.7 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
1.4 | 12.8 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
1.4 | 15.6 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
1.4 | 49.0 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
1.4 | 8.3 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
1.4 | 4.1 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
1.4 | 24.7 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
1.4 | 5.5 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
1.4 | 24.5 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
1.4 | 147.4 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
1.3 | 18.9 | GO:0031014 | troponin T binding(GO:0031014) |
1.3 | 5.3 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
1.3 | 18.2 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
1.3 | 20.8 | GO:0008301 | DNA binding, bending(GO:0008301) |
1.3 | 5.2 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
1.3 | 16.8 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
1.3 | 6.3 | GO:0070697 | activin receptor binding(GO:0070697) |
1.2 | 4.9 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
1.2 | 10.9 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
1.2 | 9.7 | GO:0015026 | coreceptor activity(GO:0015026) |
1.2 | 25.4 | GO:0042609 | CD4 receptor binding(GO:0042609) |
1.2 | 43.5 | GO:0004890 | GABA-A receptor activity(GO:0004890) GABA receptor activity(GO:0016917) |
1.2 | 26.6 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
1.2 | 12.1 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
1.2 | 21.7 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
1.2 | 28.9 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
1.2 | 3.6 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
1.2 | 7.2 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
1.2 | 22.7 | GO:0043495 | protein anchor(GO:0043495) |
1.2 | 4.8 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
1.2 | 19.0 | GO:0019841 | retinol binding(GO:0019841) |
1.2 | 320.6 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
1.2 | 26.6 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
1.2 | 1.2 | GO:0050816 | phosphothreonine binding(GO:0050816) |
1.2 | 21.9 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
1.2 | 1.2 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
1.1 | 11.5 | GO:0046875 | ephrin receptor binding(GO:0046875) |
1.1 | 26.2 | GO:0070840 | dynein complex binding(GO:0070840) |
1.1 | 3.4 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
1.1 | 9.0 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
1.1 | 29.3 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
1.1 | 15.7 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
1.1 | 24.2 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
1.1 | 21.4 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
1.1 | 7.5 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
1.1 | 4.2 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
1.1 | 3.2 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
1.0 | 2.1 | GO:0015057 | thrombin receptor activity(GO:0015057) |
1.0 | 8.3 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
1.0 | 14.5 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
1.0 | 6.1 | GO:0005119 | smoothened binding(GO:0005119) |
1.0 | 16.4 | GO:0038191 | neuropilin binding(GO:0038191) |
1.0 | 4.1 | GO:0035591 | signaling adaptor activity(GO:0035591) |
1.0 | 7.1 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
1.0 | 9.1 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
1.0 | 8.9 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
1.0 | 6.9 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
1.0 | 3.9 | GO:0050262 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
1.0 | 4.9 | GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
1.0 | 22.5 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
1.0 | 6.8 | GO:0005497 | androgen binding(GO:0005497) |
1.0 | 13.6 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
1.0 | 3.8 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
1.0 | 22.9 | GO:0042605 | peptide antigen binding(GO:0042605) |
1.0 | 17.2 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
1.0 | 6.7 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.9 | 7.6 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.9 | 24.2 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.9 | 20.4 | GO:0000976 | transcription regulatory region sequence-specific DNA binding(GO:0000976) |
0.9 | 8.2 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.9 | 8.2 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) RNA polymerase II transcription coactivator binding(GO:0001225) |
0.9 | 4.5 | GO:0099529 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
0.9 | 8.1 | GO:0032190 | acrosin binding(GO:0032190) |
0.9 | 16.1 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
0.9 | 15.2 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.9 | 16.9 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.9 | 15.9 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.9 | 19.4 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.9 | 8.7 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.9 | 2.6 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.9 | 15.5 | GO:0005522 | profilin binding(GO:0005522) |
0.8 | 3.4 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
0.8 | 3.3 | GO:0004998 | transferrin receptor activity(GO:0004998) |
0.8 | 8.3 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.8 | 10.8 | GO:0038132 | neuregulin binding(GO:0038132) |
0.8 | 2.5 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.8 | 79.3 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.8 | 4.7 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.8 | 16.5 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.8 | 7.1 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.8 | 5.4 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.8 | 17.0 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.8 | 11.6 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.8 | 3.8 | GO:0004905 | type I interferon receptor activity(GO:0004905) |
0.8 | 11.5 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.8 | 9.9 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.7 | 3.7 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.7 | 2.2 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.7 | 24.3 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.7 | 2.2 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.7 | 4.3 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.7 | 0.7 | GO:0031781 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.7 | 8.6 | GO:0030371 | translation repressor activity(GO:0030371) |
0.7 | 7.8 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.7 | 72.9 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.7 | 8.5 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.7 | 2.1 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.7 | 7.7 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.7 | 9.1 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.7 | 7.6 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) phosphatidylinositol monophosphate phosphatase activity(GO:0052744) |
0.7 | 4.7 | GO:0016015 | morphogen activity(GO:0016015) |
0.7 | 10.7 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
0.7 | 8.5 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.6 | 9.7 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.6 | 9.0 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.6 | 4.5 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.6 | 8.3 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.6 | 10.7 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.6 | 3.7 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.6 | 4.9 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.6 | 7.3 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.6 | 3.0 | GO:0098960 | postsynaptic neurotransmitter receptor activity(GO:0098960) neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
0.6 | 23.3 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.6 | 7.1 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
0.6 | 5.9 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
0.6 | 13.4 | GO:0043236 | laminin binding(GO:0043236) |
0.6 | 43.0 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.6 | 2.3 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.6 | 6.9 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.6 | 5.7 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.6 | 5.7 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.6 | 10.8 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.6 | 12.4 | GO:0070402 | NADPH binding(GO:0070402) |
0.6 | 2.2 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.6 | 2.2 | GO:0004530 | deoxyribonuclease I activity(GO:0004530) |
0.5 | 5.4 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.5 | 187.2 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.5 | 2.6 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.5 | 66.9 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.5 | 5.1 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.5 | 8.0 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
0.5 | 6.0 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.5 | 31.3 | GO:0019905 | syntaxin binding(GO:0019905) |
0.5 | 4.0 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.5 | 2.0 | GO:0030107 | HLA-A specific inhibitory MHC class I receptor activity(GO:0030107) |
0.5 | 19.7 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.5 | 2.5 | GO:0036122 | BMP binding(GO:0036122) |
0.5 | 13.3 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.5 | 2.0 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.5 | 5.2 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.5 | 14.6 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.5 | 12.1 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.5 | 4.7 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.5 | 1.4 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
0.5 | 2.8 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.5 | 9.2 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.5 | 5.0 | GO:0004568 | chitinase activity(GO:0004568) chitin binding(GO:0008061) |
0.5 | 5.4 | GO:0005542 | folic acid binding(GO:0005542) |
0.5 | 4.5 | GO:0015250 | water channel activity(GO:0015250) |
0.4 | 4.5 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.4 | 1.8 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.4 | 0.9 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.4 | 9.2 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
0.4 | 3.0 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
0.4 | 4.3 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.4 | 37.0 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.4 | 3.4 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.4 | 11.4 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.4 | 2.9 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
0.4 | 4.2 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.4 | 1.7 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.4 | 2.1 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.4 | 2.9 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.4 | 6.5 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.4 | 0.8 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.4 | 1.6 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.4 | 2.4 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.4 | 6.0 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.4 | 5.5 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.4 | 29.9 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.4 | 1.2 | GO:0000035 | acyl binding(GO:0000035) |
0.4 | 3.4 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.4 | 1.9 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.4 | 7.6 | GO:0008081 | phosphoric diester hydrolase activity(GO:0008081) |
0.4 | 1.9 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
0.4 | 3.7 | GO:0032052 | bile acid binding(GO:0032052) |
0.4 | 4.8 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.4 | 1.4 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.4 | 1.8 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.3 | 7.0 | GO:0005521 | lamin binding(GO:0005521) |
0.3 | 1.7 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.3 | 4.5 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.3 | 3.1 | GO:0031432 | titin binding(GO:0031432) |
0.3 | 0.7 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
0.3 | 2.0 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.3 | 23.1 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.3 | 3.7 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.3 | 4.0 | GO:0005351 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
0.3 | 0.9 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
0.3 | 8.8 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.3 | 5.6 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.3 | 4.7 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.3 | 2.3 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
0.3 | 2.3 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.3 | 1.1 | GO:0000150 | recombinase activity(GO:0000150) |
0.3 | 1.7 | GO:0008948 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) oxaloacetate decarboxylase activity(GO:0008948) |
0.3 | 2.7 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.3 | 5.2 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.3 | 1.4 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.3 | 2.7 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.2 | 3.0 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.2 | 67.4 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.2 | 1.9 | GO:0019158 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.2 | 2.4 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.2 | 5.5 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.2 | 1.9 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.2 | 13.4 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.2 | 0.9 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.2 | 3.5 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.2 | 1.9 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.2 | 2.6 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.2 | 3.1 | GO:0031491 | nucleosome binding(GO:0031491) |
0.2 | 2.4 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
0.2 | 2.7 | GO:0008527 | taste receptor activity(GO:0008527) |
0.2 | 2.6 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.2 | 0.9 | GO:0019863 | IgE binding(GO:0019863) |
0.2 | 2.3 | GO:0016723 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor(GO:0016723) |
0.2 | 0.6 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.2 | 3.9 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
0.2 | 8.6 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.2 | 192.9 | GO:0003700 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.2 | 1.1 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.2 | 3.0 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.2 | 0.9 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.2 | 0.6 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.2 | 2.6 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.2 | 1.0 | GO:0039552 | RIG-I binding(GO:0039552) |
0.2 | 5.3 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.2 | 28.7 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.2 | 2.6 | GO:0004950 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.2 | 7.8 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.2 | 3.4 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 2.1 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.1 | 0.9 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.1 | 3.2 | GO:0015297 | antiporter activity(GO:0015297) |
0.1 | 3.2 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.1 | 6.2 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.1 | 1.4 | GO:0031404 | chloride ion binding(GO:0031404) |
0.1 | 0.5 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 1.7 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.1 | 1.7 | GO:0071617 | lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.1 | 0.4 | GO:0004914 | interleukin-5 receptor activity(GO:0004914) |
0.1 | 2.1 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.1 | 2.0 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.1 | 1.9 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 0.5 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
0.1 | 3.7 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 2.3 | GO:1901981 | phosphatidylinositol phosphate binding(GO:1901981) |
0.1 | 3.8 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.1 | 2.0 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 2.4 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.1 | 1.5 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.1 | 0.6 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.1 | 1.9 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.1 | 3.5 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.1 | 0.3 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
0.1 | 0.3 | GO:0070984 | SET domain binding(GO:0070984) |
0.1 | 0.3 | GO:0034618 | nitric-oxide synthase activity(GO:0004517) arginine binding(GO:0034618) |
0.1 | 0.2 | GO:0032135 | DNA insertion or deletion binding(GO:0032135) single base insertion or deletion binding(GO:0032138) |
0.1 | 2.5 | GO:0032934 | sterol binding(GO:0032934) |
0.1 | 0.9 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 1.2 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 0.5 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.1 | 16.9 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.1 | 1.1 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 1.1 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.1 | 0.6 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.0 | 0.7 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.0 | 0.2 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.0 | 0.3 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.0 | 1.4 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
0.0 | 8.5 | GO:0004888 | transmembrane signaling receptor activity(GO:0004888) |
0.0 | 1.1 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.0 | 0.4 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 127.6 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
1.9 | 91.8 | PID REELIN PATHWAY | Reelin signaling pathway |
1.8 | 64.5 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
1.7 | 5.2 | PID IL3 PATHWAY | IL3-mediated signaling events |
1.7 | 8.4 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
1.7 | 11.6 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
1.6 | 18.7 | ST ADRENERGIC | Adrenergic Pathway |
1.4 | 20.2 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
1.4 | 41.6 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
1.4 | 61.5 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
1.4 | 32.5 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
1.3 | 26.7 | ST GAQ PATHWAY | G alpha q Pathway |
1.3 | 31.8 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
1.2 | 16.4 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
1.1 | 9.5 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
1.0 | 33.0 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
1.0 | 8.1 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
1.0 | 11.9 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.9 | 14.4 | PID ALK2 PATHWAY | ALK2 signaling events |
0.9 | 3.6 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.9 | 5.3 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.9 | 49.4 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.8 | 15.8 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.8 | 21.2 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.7 | 19.9 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.7 | 22.0 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.7 | 7.2 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.7 | 28.0 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.7 | 19.1 | PID BARD1 PATHWAY | BARD1 signaling events |
0.7 | 11.6 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.7 | 24.9 | PID INSULIN PATHWAY | Insulin Pathway |
0.7 | 20.1 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.7 | 35.9 | PID BCR 5PATHWAY | BCR signaling pathway |
0.7 | 27.1 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.7 | 16.5 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.7 | 36.4 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.7 | 15.1 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.7 | 18.4 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.6 | 44.5 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.6 | 85.0 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.6 | 15.0 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.6 | 5.6 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.6 | 9.2 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.6 | 5.4 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.6 | 10.2 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.6 | 16.2 | PID RAS PATHWAY | Regulation of Ras family activation |
0.6 | 10.7 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.5 | 3.8 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.5 | 10.9 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.5 | 8.1 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.5 | 5.8 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.5 | 4.2 | PID EPO PATHWAY | EPO signaling pathway |
0.5 | 13.0 | PID LKB1 PATHWAY | LKB1 signaling events |
0.5 | 20.6 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.5 | 23.2 | PID FGF PATHWAY | FGF signaling pathway |
0.5 | 18.1 | PID RHOA PATHWAY | RhoA signaling pathway |
0.5 | 6.0 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.4 | 2.1 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.4 | 8.9 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.4 | 4.6 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.4 | 9.5 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.4 | 12.0 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.3 | 8.0 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.3 | 54.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.3 | 2.6 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.3 | 7.6 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.3 | 13.9 | PID NOTCH PATHWAY | Notch signaling pathway |
0.3 | 3.4 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.3 | 13.1 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.3 | 8.5 | PID ARF6 PATHWAY | Arf6 signaling events |
0.3 | 15.8 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.3 | 1.8 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.3 | 4.2 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.3 | 8.4 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.3 | 6.9 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.2 | 8.3 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.2 | 1.4 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.2 | 18.2 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.2 | 2.7 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.2 | 4.4 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.2 | 4.6 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.2 | 2.9 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.2 | 2.9 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.2 | 3.2 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.2 | 1.1 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 6.0 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 1.4 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 0.4 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 1.3 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 4.0 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 2.0 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 1.3 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 1.4 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 16.1 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 3.4 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 2.0 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.1 | 1.1 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 1.6 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 0.4 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.0 | 1.5 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.4 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 2.5 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 5.2 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 3.1 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.5 | 13.6 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
3.3 | 69.2 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
3.0 | 54.4 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
2.6 | 69.9 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
2.3 | 42.1 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
2.3 | 13.6 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
1.9 | 26.9 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
1.8 | 12.5 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
1.7 | 10.4 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
1.7 | 82.5 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
1.7 | 87.4 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
1.6 | 39.1 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
1.6 | 84.9 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
1.6 | 29.7 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
1.6 | 12.4 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
1.5 | 47.3 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
1.4 | 79.4 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
1.4 | 15.5 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
1.4 | 12.7 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
1.4 | 28.1 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
1.3 | 26.8 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
1.3 | 35.6 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
1.2 | 18.6 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
1.2 | 21.9 | REACTOME GABA B RECEPTOR ACTIVATION | Genes involved in GABA B receptor activation |
1.2 | 23.5 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
1.2 | 41.9 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
1.2 | 29.0 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
1.1 | 21.1 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
1.1 | 21.6 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
1.0 | 20.7 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
1.0 | 23.8 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
1.0 | 15.2 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
1.0 | 24.9 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
1.0 | 15.9 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
1.0 | 17.3 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.9 | 30.4 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.9 | 22.1 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.9 | 3.6 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.9 | 53.5 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.9 | 36.2 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
0.9 | 0.9 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.9 | 11.3 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.8 | 8.4 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.8 | 66.6 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.8 | 11.8 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.8 | 7.7 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.8 | 2.3 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.8 | 1.5 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.7 | 26.2 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.7 | 9.7 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.7 | 65.5 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.7 | 45.8 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.7 | 28.6 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.7 | 23.4 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.7 | 7.8 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.7 | 9.0 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.7 | 6.1 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.7 | 23.8 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.7 | 29.2 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.7 | 8.1 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.7 | 54.2 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.7 | 17.9 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.6 | 13.5 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.6 | 88.1 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.6 | 8.9 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.6 | 18.9 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.6 | 22.6 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.6 | 10.5 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.6 | 29.5 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.6 | 22.2 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.6 | 4.0 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.6 | 10.5 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.5 | 7.1 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.5 | 10.4 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.5 | 7.4 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.5 | 3.8 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.5 | 14.2 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.5 | 13.1 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.5 | 9.3 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.5 | 5.1 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.4 | 8.5 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.4 | 8.9 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.4 | 7.4 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.4 | 3.9 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.4 | 2.9 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.4 | 6.6 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.4 | 18.2 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.4 | 12.0 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.4 | 5.1 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.4 | 4.2 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.3 | 7.2 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.3 | 22.6 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.3 | 18.1 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.3 | 8.0 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.3 | 23.2 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.3 | 6.9 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.3 | 1.2 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.3 | 11.0 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.3 | 23.6 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.2 | 6.6 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.2 | 2.9 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.2 | 5.7 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.2 | 3.1 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.2 | 10.2 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.2 | 4.4 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.2 | 3.1 | REACTOME DEFENSINS | Genes involved in Defensins |
0.2 | 6.6 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.2 | 5.7 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.2 | 13.9 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.2 | 5.5 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.2 | 2.8 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.2 | 7.5 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.2 | 5.5 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.2 | 0.4 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.2 | 10.1 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.2 | 2.4 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.2 | 3.2 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.2 | 3.0 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.2 | 1.9 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.2 | 3.2 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.2 | 3.2 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 1.6 | REACTOME SHC MEDIATED CASCADE | Genes involved in SHC-mediated cascade |
0.1 | 2.2 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.1 | 1.6 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 1.2 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 23.9 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.1 | 2.4 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.1 | 1.8 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.0 | 0.6 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.0 | 0.2 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.4 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 0.3 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |